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Abstract
Accurate diagnosis of disease is of fundamental importance in clinical practice and medical research. Before
a medical diagnostic test is routinely used in practice, its ability to distinguish between diseased and nondiseased
states must be rigorously assessed through statistical analysis. The receiver operating characteristic (ROC) curve
is the most popular used tool for evaluating the discriminatory ability of continuous-outcome diagnostic tests. It
has been acknowledged that several factors (e.g., subject-specific characteristics, such as age and/or gender) can
affect the test’s accuracy beyond disease status. Recently, the covariate-adjusted ROC curve has been proposed and
successfully applied as a global summary measure of diagnostic accuracy that takes covariate information into account.
We motivate the use of the covariate-adjusted ROC curve and develop a highly robust model based on a combination
of B-splines dependent Dirichlet process mixture models and the Bayesian bootstrap. Multiple simulation studies
demonstrate the ability of our model to successfully recover the true covariate-adjusted ROC curve and to produce
valid inferences in a variety of complex scenarios. Our methods are motivated by and applied to an endocrine study
where the main goal is to assess the accuracy of the body mass index, adjusted for age and gender, for predicting
clusters of cardiovascular disease risk factors. The R-package AROC, implementing our proposed methods, is provided.
key words: Bayesian bootstrap; Covariate-adjustment; Diagnostic test; Dependent Dirichlet process
mixtures; Receiver operating characteristic curve
1 INTRODUCTION
Evaluating the performance of medical tests for screening and diagnosing disease is of great importance in
clinical practice and medical research. Prior to approving the use of a diagnostic test in routine practice,
Vanda Ina´cio de Carvalho, School of Mathematics, University of Edinburgh, Scotland, UK (Vanda.Inacio@ed.ac.uk). Mar´ıa
Xose´ Rodr´ıguez-A´lvarez, BCAM-Basque Center for Applied Mathematics & IKERBASQUE, Basque Foundation for Science,
Bilbao, Basque Country, Spain (mxrodriguez@bcamath.org).
1
ar
X
iv
:1
80
6.
00
47
3v
1 
 [s
tat
.M
E]
  3
0 M
ay
 20
18
its ability to distinguish diseased from nondiseased individuals must be rigorously vetted through statistical
analysis. Throughout this article we use the terms ‘medical test’ and ‘diagnostic test’ to broadly include any
continuous classifier (e.g., a single biological marker or a composite univariate score obtained from a combina-
tion of multiple biomarkers) for a well-defined condition (termed ‘disease’, with ‘nondiseased’ used to indicate
the absence of the condition).
The receiver operating characteristic (ROC) curve is the most popular graphical tool to assess the perfor-
mance of continuous outcome diagnostic tests in discriminating between diseased and nondiseased states. It is
a plot of pairs of true positive fraction (or sensitivity) against the false positive fraction (or 1-specificity) for all
possible threshold values that can be used to convert continuous outcomes into dichotomous ones. Specifically,
let YD and YD¯ be continuous random variables denoting the diagnostic test outcomes in the diseased and
nondiseased groups, respectively, with cumulative distribution functions given by FD and FD¯. Further, let
c ∈ R be a threshold value for defining a positive test result. Without loss of generality, we assume that a
subject is classified as diseased (nondiseased) if the test outcome is equal or greater (less) than c. Hence, each
threshold value c chosen will give rise to a true positive fraction, TPF(c) = Pr(YD ≥ c) = 1−FD(c) (the prob-
ability that a diseased subject tests positive), and a false positive fraction, FPF(c) = Pr(YD¯ ≥ c) = 1− FD¯(c)
(the probability that a nondiseased subject tests positive). The ROC curve is defined as the the set of all
FPF−TPF pairs that can be obtained on the threshold value c varying, i.e., {FPF(c),TPF(c) : c ∈ R}. If we
let the FPF at threshold c to be t, i.e., t = FPF(c) = 1 − FD¯(c), the ROC curve can be equivalently written
as {(t,ROC(t)) : t ∈ [0, 1]}, where
ROC(t) = Pr{YD > F−1D¯ (1− t)} = 1− FD{F−1D¯ (1− t)}, 0 ≤ t ≤ 1.
When the distributions of test outcomes in the diseased and nondiseased groups completely overlap, the ROC
curve is the diagonal line of the unit square (that is, TPF(c) = FPF(c) for all c), thus indicating a useless test.
On the other hand, the more separated the distributions the closer the ROC curve is to the point (0, 1) in the
unit square. A curve that reaches the point (0, 1) has TPF(c) = 1 and FPF(c) = 0 for some threshold c, and
hence corresponds to a perfect test. Related to the ROC curve, several indexes can be used as summaries of
the accuracy of a diagnostic test. The area under the ROC curve (AUC),
∫ 1
0 ROC(t)dt, is the one most widely
used. For a test that perfectly discriminates diseased individuals from nondiseased ones, AUC = 1, while for
a useless test AUC = 0.5.
Recently, it has been acknowledged that other factors can affect test’s accuracy beyond disease status;
examples of such factors include different test settings and subject-specific characteristics (e.g., age and gender).
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Whenever available, covariate information must be incorporated in ROC analysis as failure to do so might
result in oversimplified and biased conclusions about a test’s accuracy (see, e.g., Pardo-Ferna´ndez et al., 2014,
Section 2), whereas stratifying by covariates might be impractical for continuous ones. Denoting as XD and
XD¯ the diseased and nondiseased vector of covariates we are interested in, the covariate-specific ROC curve,
given a covariate value x, is
ROC(t | x) = Pr{YD > F−1D¯ (1− t | XD¯ = x) | XD = x}
= 1− FD{F−1D¯ (1− t | XD¯ = x) | XD = x},
where FD(y | XD = x) = Pr(YD ≤ y | XD = x) is the conditional cumulative distribution function for YD
conditional on XD = x and with FD¯(y | XD¯ = x) being similarly defined. Similarly to the unconditional case,
the covariate-specific AUC is AUC(x) =
∫ 1
0 ROC(t | x)dt. Note that for each possible value x we might obtain
a different ROC curve/AUC and therefore a possibly different diagnostic accuracy. The covariate-specific ROC
curve is, therefore, an important tool that helps to understand the optimal and suboptimal populations where
to perform the tests on.
Although the covariate-specific ROC curve and corresponding AUC depict the accuracy of the test for every
possible covariate value x that we might be interested in, it would be undoubtedly useful to have a global
summary measure that also takes covariate information into account. Such summary measure was developed
by Janes and Pepe (2009), who proposed the covariate-adjusted ROC (AROC) curve, defined as
AROC(t) =
∫
ROC(t | x)dHD(x),
where HD(x) = Pr(XD ≤ x) is the cumulative distribution function of XD. That is, the AROC curve is
an average of covariate-specific ROC curves, weighted according to the distribution of the covariates in the
diseased group. The covariate-adjusted AUC (AAUC) is thus expressed as
AAUC =
∫ 1
0
AROC(t)dt =
∫ 1
0
∫
ROC(t | x)dHD(x)dt =
∫
AUC(x)dHD(x).
Note that the AAUC is also a weighted average of covariate-specific AUCs. Janes and Pepe (2009) shown that
the AROC can be equivalently represented as
AROC(t) = Pr{YD > F−1D¯ (1− t | XD)}
= Pr{1− FD¯(YD | XD) ≤ t}. (1)
This representation makes clear that the AROC at a FPF of t is the overall true positive fraction when the
thresholds used for defining a positive test are covariate-specific and chosen to ensure that the FPF is t in each
3
subpopulation defined by the covariate values. The AROC thus summarises the covariate-specific performance
of the test and is particularly useful when sample sizes are reduced and covariate-specific ROC curves cannot
be estimated precisely.
In this paper, besides providing insight about the AROC curve and its relationship to the pooled ROC
curve and the covariate-specific ROC curve, we develop a Bayesian nonparametric approach to obtain data-
driven inference for the AROC curve and the AAUC. Specifically, our method combines a B-splines dependent
Dirichlet process mixture model to estimate the conditional cumulative distribution function of test outcomes
in the nondiseased population FD¯(· | XD¯ = x) and the Bayesian bootstrap to estimate the outside probability
in (1). This results in a highly flexible estimator that can adapt to intricate distributional features, such as
nonlinearities, multimodality, skewness, and/or extreme variability, without the need to know them in advance.
Hence, the Bayesian nonparametric model we propose is a widely applicable approach to inference for the
AROC/AAUC that can be used for many populations and for a large number of diseases and continuous
diagnostic measures. To the best of our knowledge, the only literature on estimating the AROC involves
semiparametric linear models (Janes and Pepe, 2009) and kernel-type of estimators (Rodr´ıguez-A´lvarez et al.,
2011b). We also mention the work of Guan et al. (2012) where semiparametric techniques for estimating the
AROC are adopted, but the method is only devised for categorical covariates thus limiting its applicability in
practice. Compared to these approaches, our method has a number of advantages, namely: (i) in contrast to
Janes and Pepe (2009), by using B-splines regression we overcome the linearity assumption which, more often
than not, is violated in practice, and (ii) by opposition to the kernel type of approach, we allow the entire
distribution of test outcomes to smoothly change as a function of the covariates, and not only the mean and
variance. Besides, and even more importantly, we can easily handle multiple covariates, either continuous or
categorical. Further, point estimates and credible intervals for the AROC curve and its corresponding AAUC
are obtained in a single integrated framework. Software is provided in the R package (R Core Team, 2018)
AROC available on https://CRAN.R-project.org/package=AROC. Recent developments of Bayesian flexible
models that have been successfully applied in medical diagnostic testing research abound (Erkanli et al., 2006;
Branscum et al., 2008, 2015; Gu et al., 2008; Hanson et al., 2008; Ina´cio et al., 2011; Ina´cio de Carvalho et al.,
2013, 2017; Inacio de Carvalho et al., 2018; Rodr´ıguez and Mart´ınez, 2013; Hwang and Chen, 2015; Zhao et al.,
2016; Ina´cio de Carvalho and Branscum, 2018).
The remainder of this paper is organised as follows. In the next section, we provide deep reasoning about
the AROC curve. In Section 3 we introduce our new approach to Bayesian nonparametric inference for
the AROC curve and the AAUC. The performance of our methods is validated in Section 4 using multiple
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simulation studies. Section 5 applies our methods to assess the accuracy of the body mass index, adjusted for
age and gender, for predicting clusters of cardiovascular disease risk factors. Concluding remarks are provided
in Section 6. Some technical details and extra simulations are available in (Web) Appendices, where we also
describe the R-package AROC that accompanies this paper.
2 MOTIVATIONAL EXAMPLES
We shed light on the differences and similarities among the pooled or marginal ROC curve (obtained by pooling
the test outcomes in each group altogether regardless of the covariate values), the covariate-specific ROC curve
and the AROC curve introduced in the previous section. It may be surprising that the pooled/marginal ROC
curve is not an average of covariate-specific ROC curves and, thus, it does not always coincide with the AROC.
We start by re-expressing the different ROC curves (pooled/marginal, covariate-specific and AROC) in
such a way that the differences and similarities become clearer. Associated with each threshold value c ∈ R,
we may define the marginal (t) and covariate-specific (tx) FPF as follows
t = Pr(YD¯ > c),
tx = Pr(YD¯ > c | XD¯ = x).
We note that (Pepe, 2003, Chapter 6),
t = Pr(YD¯ > c) =
∫
Pr(YD¯ > c | XD¯ = x)dHD¯(x) =
∫
txdHD¯(x), (2)
where HD¯(x) = Pr (XD¯ ≤ x). Thus, for a particular threshold value c, the marginal FPF, t, is a weighted
average of covariate-specific FPFs, tx, when the same threshold value c is used for defining a positive test
result in each of the subpopulations defined by the covariates. On the other hand, by specifying the FPF, t,
we are interested in, it is possible to define the covariate-specific threshold values cx which give rise to a FPF
of t in each of the subpopulations defined by the covariates, i.e.,
cx = F
−1
D¯
(1− t | XD¯ = x) .
Bearing this in mind, the covariate-specific, pooled/marginal and AROC curves can be expressed, respectively,
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as follows
ROC(t | x) = Pr(YD > cx | XD = x),
ROC(t) = Pr(YD > c) =
∫
Pr(YD > c | XD = x)dHD(x) =
∫
ROC(tx | x)dHD(x), (3)
AROC(t) =
∫
ROC(t | x)dHD(x) =
∫
Pr(YD > cx | XD = x)dHD(x). (4)
Thus, the marginal/pooled ROC curve, ROC(·), and the AROC, AROC(·), can both be expressed in terms
of covariate-specific ROC curves, ROC(· | x). However, there are important differences. An operating point
(i.e., a FPF-TPF pair), in the marginal/pooled ROC curve is obtained by using a common threshold value
for defining a positive test result in each of the subpopulations defined by the covariates. The marginal FPF
at threshold c is then the average of covariate-specific FPFs (using c as threshold), weighted according to the
distribution of the covariates in the nondiseased group (see (2)). The same applies to the marginal TPF (i.e.,
the ROC curve), but here the weights correspond to the distribution of the covariates in the diseased group
(see (3)). On the other hand, an operating point in the AROC is obtained by using covariate-specific threshold
values, cx, which ensure the same (covariate-specific) FPF across the subpopulations. The TPF, in this case,
is the average of covariate-specific TPFs calculated at the covariate-specific thresholds (see (4)).
In Figure 1 we offer deeper insight into the practical implications of these differences. In all cases, we
consider a single continuous covariate (although results generalise to multiple covariates, both continuous and
categorical) that might or might not be associated with the diagnostic test outcome, and that might or might
not impact its diagnostic accuracy. Figure 1(a) depicts the pooled/marginal and AROC curves in a situation in
which the covariate is not associated with the diagnostic test outcome (YD¯ ∼ N(0.5, 0.32) and YD ∼ N(1, 0.32)).
In this case, it is easy to show that the covariate-specific ROC curve is the same for all covariate values, and it
coincides with both the pooled/marginal ROC curve and the AROC. In turn, in Figures 1(b) and 1(c) we show
several examples where the covariate is associated with the diagnostic test outcome. For the examples shown
in Figure 1(b), the covariate does not impact the accuracy of the diagnostic test (YD¯ ∼ N(0.5 +XD¯, 0.32) and
YD ∼ N(0.75 +XD, 0.32)). Thus, the covariate-specific ROC curve is the same for all covariate values, and it
coincides with the AROC. On the other hand, for the examples shown in Figure 1(c), the covariate does have
an impact on diagnostic accuracy, and thus we have a different covariate-specific ROC curve for each possible
covariate value (YD¯ ∼ N(0.25 + 0.5XD¯, 0.32) and YD ∼ N(0.75 + XD, 0.32)). Here, the larger the covariate
value, the better the diagnostic accuracy. In both Figures 1(b) and 1(c), the left-hand side plots show the
pooled/marginal ROC curve and the AROC when the covariate has the same distribution in the nondiseased
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and diseased groups (XD¯ ∼ N(0, 0.152) and XD ∼ N(0, 0.152)). Note that this implies that the covariate
is not associated with disease status. Under this assumption, and assuming that the covariate-specific ROC
curves are concave, it can be shown that the pooled ROC curve lies below (i.e., is attenuated with respect to)
the AROC (see Appendix A). The amount of separation will depend on the strength of association between the
covariate and the diagnostic test outcome (Janes and Pepe, 2008b). Even when the discriminatory capacity of
the test is not affected by the covariate (Figure 1(b)), the pooled ROC curve does not coincide with the common
covariate-specific ROC curve or AROC. The reason behind is that the threshold that gives rise to a particular
operating point on the common covariate-specific ROC curve may not be the same in each subpopulation
defined by the covariate (see, e.g., Janes and Pepe, 2008a,b; Pardo-Ferna´ndez et al., 2014). However, the
pooled ROC curve is based on averaging covariate-specific FPFs and TPFs at a common threshold. Perhaps
even more surprising are the results shown in the middle- and right-hand side of Figures 1(b) and 1(c), where
differences between the pooled ROC curve and the AROC are more marked and in opposite directions. These
plots show the situation where the covariate is associated with disease status. In this case, the pooled ROC
curve will “incorporate” the portion of diagnostic accuracy attributable to the covariate. The middle-hand
plots show the situation where large values of the covariate are associated with the disease (XD¯ ∼ N(0, 0.152)
and XD ∼ N(0.4, 0.152)), and thus, for this example, the pooled ROC curve lies above the AROC (optimistic
result). On the other hand, the right-hand plots show the situation where the larger the covariate, the more
likely the individual will be nondiseased (XD¯ ∼ N(0.4, 0.152) and XD ∼ N(0, 0.152)). In this case and for this
example, the pooled ROC curve lies below the AROC (pessimistic result). We would like to mention that the
above examples represent particular cases. In general, the ‘relation’ between the AROC curve and the pooled
ROC curve might be more complex (with, e.g., the curves crossing), as illustrated in the simulation study
reported in Section 4.
Summarising, in those situations where the diagnostic test outcome is affected by covariates (though not
necessarily its discriminatory capacity), covariate information must be incorporated into the ROC analysis.
If a classification rule is used that relies on the same threshold value for all populations (by pooling the data
regardless of the values of the covariate), this will result in the test having a diagnostic accuracy that is biased
vis-a`-vis its ‘true potential’ diagnostic accuracy. As a result, optimistic or pessimistic results can be obtained,
and by extension, misleading conclusions. In such circumstances it is, therefore, advisable to report, when
possible, the covariate-specific ROC curves, and, as a global summary of the covariate-specific performance of
the test, the AROC.
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3 BAYESIAN NONPARAMETRIC MODEL FOR THE COVARIATE-ADJUSTED ROC CURVE
In this section we detail our nonparametric regression model for conducting inference about the covariate-
adjusted ROC curve. We start by noting that
AROC(t) = Pr{YD > F−1D¯ (1− t | XD)} = Pr{1− FD¯(YD | XD) ≤ t} = Pr(UD ≤ t), 0 ≤ t ≤ 1,
where the random variable UD = 1−FD¯(YD | XD) is the so-called placement value of the test outcome in the
diseased population, i.e., the standardisation of YD to the conditional distribution of YD¯. Thus, the AROC can
be interpreted as the cumulative distribution function of UD. Our modelling procedure involves three steps: 1)
modelling the conditional distribution of test outcomes in the nondiseased group, FD¯(· | XD¯ = x), which we do
by using a B-splines dependent Dirichlet process mixture of normals model, 2) computing the placement value
UD, and 3) modelling the cumulative distribution function of UD, which we do also nonparametrically through
the Bayesian bootstrap. In what follows, we assume that {(xD¯i, yD¯i)}nD¯i=1 and {(xDj , yDj)}nDj=1 are random
samples of size nD¯ and nD from the nondiseased and diseased populations, respectively. Further, for all
i = 1, . . . , nD¯ and j = 1, . . . , nD, let xD¯i = (xD¯i,1, . . . , xD¯i,p)
′ and xDj = (xDj,1, . . . , xDj,p)′ be p−dimensional
vectors of covariates. To avoid notational overhead, we assume that all covariates are continuous. However,
our modelling approach can easily deal with categorical covariates (through, as usual, dummy variables), as
well as, with the interaction between continuous and categorical covariates.
3.1 Three step modelling approach
Step 1. Modelling FD¯(· | XD¯ = x)
In a single-weights dependent Dirichlet process mixture of normals model (De Iorio et al., 2009), the conditional
distribution FD¯(yD¯i | xD¯i) is modelled as
FD¯(yD¯i | XD¯ = xD¯i) =
∫
Φ(yD¯i | µ(xD¯i;β), σ2)dG(β, σ2), (5)
where Φ(y | µ, σ2) is the cumulative function of the normal distribution with mean µ and variance σ2, evaluated
at y, and G follows the Dirichlet process (DP) prior (Ferguson, 1973), with base measure E(G) = G0(β, σ
2)
and precision parameter α > 0, denoted by G ∼ DP(α,G0). The parameter α determines, among other
properties, the variation of G around G0, with smaller (larger) values of α implying higher (lower) uncertainty.
For ease of modelling, we express the DP prior G in the stick-breaking form (Sethuraman, 1994) as
G(·) =
∞∑
l=1
ωlδ(βl,σ2l )
(·), ωl = vl
∏
r<l
(1− vr), (6)
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where δa denotes a point mass at a, vl
iid∼ Beta(1, α) and (βl, σ2l )
iid∼ G0 are mutually independent, for l ≥ 1.
This stick-breaking representation of the DP allows us to rewrite (5) as
FD¯(yD¯i | XD¯ = xD¯i) =
∞∑
l=1
ωlΦ(yD¯i | µ(xD¯i;βl), σ2l ).
Regarding the specification of µ(xD¯i;βl), the usual, but somewhat rigid, choice is to assume a linear combi-
nation of the covariates in each component, i.e,
µ (xD¯i;βl) = µl(xD¯i) = βl0 + βl1xD¯i,1 + · · ·+ βlpxD¯i,p = x∗′¯Diβl,
where x∗′¯
Di
= (1,x′¯
Di
). However, this formulation implies that the expected test outcome changes linearly
with the covariates, E(yD¯i | xD¯i) =
∑∞
l=1 ωlx
∗′¯
Di
βl = x
∗′¯
Di
β¯, with the hth component of the vector β¯ being∑∞
l=1 ωlβlh, for h = 0, . . . , p. To allow for greater flexibility and since nonlinear relationships between test
results and continuous covariates often occur in practice, in this paper we assume a flexible model for the
mean of each component
µl(xD¯i) = βl0 + fl1(xD¯i,1) + · · ·+ flp(xD¯i,p), (7)
where flh(·) are smooth and unknown functions, l ≥ 1 and h = 1, . . . , p. In particular, we propose to
approximate each smooth function flh(·) by a linear combination of cubic B-splines basis functions defined
over a sequence of knots ξh0 < ξh1 < · · · < ξhKh < ξh,Kh+1, h = 1, . . . , p. The knots ξh0 and ξhKh+1 are
boundary knots, while the remaining ones are interior knots. Thus, model (7) is then expressed as
µl(xD¯i) = βl0 +B
′
ξ1(xD¯i,1)βl1︸ ︷︷ ︸
fl1(xD¯i,1)
+ · · ·+B′ξp(xD¯i,p)βlp︸ ︷︷ ︸
flp(xD¯i,p)
= z′¯Diβl,
where Bξh(xD¯i,h) = (Bh1(xD¯i,h), . . . , Bh,Kh+3(xD¯i,h))
′, with Bhk(x) denoting the kth cubic B-spline basis func-
tion (evaluated at x) defined by the vector of knots ξh (De Boor, 1978, Chapter 9), and βlh = (βlh1, . . . , βlh,Kh+3)
′,
for l ≥ 1 and h = 1, . . . , p. Finally, z′¯
Di
= (1,B′ξ1(xD¯i,1), . . . ,B
′
ξp
(xD¯i,p)) and βl = (βl0,β
′
l1, . . . ,β
′
lp)
′. In gen-
eral, both the number and location of the knots that characterise the B-splines basis functions have the
potential to influence inferences, more so for the former rather than the latter. As noted by Durrleman and
Simon (1989), in practice, only a few number of knots are needed to adequately describe most of the phe-
nomena likely to be observed in medical studies. According to the authors, a maximum of three or four knots
will often be enough. Here, the selection of the number of knots is assisted by a model selection criterion,
for example, the log pseudo marginal likelihood (LPML) (Geisser and Eddy, 1979) or the widely applicable
information criterion (WAIC) (Gelman et al., 2014). With regard to the location of the Kh interior knots, we
9
use the quantiles of xD¯,h = (xD¯1,h, . . . , xD¯nD¯,h)
′, h = 1, . . . , p. Particularly, following Rosenberg (1995), ξhk is
set equal to the k/(Kh + 1) quantile of xD¯,h, for k = 1, . . . ,Kh. This assures an approximate equal number of
observations at each interval defined by the knots. The boundary knots ξh0 and ξh,Kh+1 are set equal to the
minimum and maximum of xD¯,h, respectively.
To complete our model we specify a conditionally conjugate base measure, which greatly simplifies com-
putations, namely
(βl, σ
2
l )
iid∼ NQ(βl |m,S)Γ(σ−2l | a, b),
with conjugate hyperprior m ∼ NQ(m0,S0) and S−1 ∼W(ν, (νΨ)−1), where Q denotes the dimension of vector
zD¯. Here Γ(· | a, b) denotes a gamma distribution with shape a and rate b and W(ν, (νΨ)−1) denotes a Wishart
distribution with ν degrees of freedom and expectation Ψ−1. For ease of posterior of simulation and because
it provides a highly accurate approximation we use the blocked Gibbs sampler of Ishwaran and James (2001),
which relies on truncating the stick-breaking representation in (6) to a finite number of components, say L.
Therefore, our B-splines dependent Dirichlet process mixture of normals model, hereafter shortly referred to
as B-splines DDP, for the conditional distribution of test outcomes in the nondiseased group is expressed as
FD¯(yD¯i | XD¯ = xD¯i) =
L∑
l=1
ωlΦ(yD¯i | z′¯Diβl, σ2l ),
where L is pre-specified, the ωl’s result from a truncated version of the stick-breaking construction: ω1 = v1,
ωl = vl
∏
r<l(1 − vr), for l = 2, . . . , L, v1, . . . , vL−1 iid∼ Beta(1, α), and vL = 1. Note that L is not the ex-
act number of components we expect to observe but instead an upper bound on the number of components.
An appropriate value of L can be determined by considering properties of the high-order ωl values in the
infinite sum representation (6). Specifically, Ishwaran and Zarepour (2000) shown that E(
∑∞
l=L+1 ωl | α) =
αL(1 + α)−L. For example, setting α = 1 and L = 10, as in our simulation studies and application, leads to
E(
∑∞
l=L+1 ωl) ≈ 0.00098, so the truncation error is about 0.1%. The conditional distribution is then estimated
by a finite mixture of normal regression models with the mixing weights automatically determined by the data.
The full conditional distributions have the conjugate forms detailed in Web Appendix A of the Supplementary
Materials.
Step 2. Modelling the placement value UD
Once the Step 1 has been done, it is rather straightforward to model the placement value UD. Given a
posterior sample from the parameters of interest
(
ω
(s)
1 , . . . , ω
(s)
L ,β
(s)
1 , . . . ,β
(s)
L , (σ
(s)
1 )
2, . . . , (σ
(s)
L )
2
)
, we compute
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the corresponding realisation of the placement value of a diseased subject in the nondiseased population as
U
(s)
Dj = 1− F (s)D¯ (yDj | xDj) = 1−
L∑
l=1
ω
(s)
l Φ
(
yDj | z′Djβ(s)l , (σ(s)l )2
)
, j = 1, . . . , nD, s = 1, . . . , S,
where S denotes the number of posterior samples after burn-in and z′Dj = (1,B
′
ξ1
(xDj,1), . . . ,B
′
ξp
(xDj,p)).
Step 3. Modelling the cumulative distribution function of UD
The last step in our modelling strategy to estimate the AROC involves the need of estimating the cumulative
distribution function of UD. We propose to it do through the Bayesian bootstrap (BB) proposed by Rubin
(1981). In Efron’s frequentist nonparametric bootstrap (Efron, 1979), for a bootstrap sample of size n, the
weights associated to each observation belong to the discrete set {0, 1/n, . . . , n/n}, corresponding to the number
of times each observation appears in such bootstrap sample. By opposition, in the Bayesian bootstrap, the
weights are considered unknown, and their posterior distribution is derived. Rubin (1981) showed that, by
considering a non-informative prior for the weights, samples from the BB correspond to discrete distributions
supported at the observed data points with weights distributed according to a Dirichlet(n; 1, . . . , 1) distribution.
Thus, the weights in the BB are smoother than those from the classical bootstrap. Note that in the BB data
should be regarded as fixed, so that we do not resample from it. Interestingly, the BB has also connections
with the DP; specifically, by letting the precision parameter α converging to zero, the BB can be regarded as
a noninformative version of the DP (Gasparini, 1995, Theorem 2).
According to the BB, given a posterior realisation from U
(s)
Dj , j = 1, . . . , nD (available from Step 2), a
posterior realisation for the cumulative distribution function of UD, i.e., for the AROC curve, can be computed
as
AROC(s)(t) =
nD∑
j=1
q
(s)
j I(U
(s)
Dj ≤ t), (q(s)1 , . . . , q(s)nD) ∼ Dirichlet(nD; 1, . . . , 1), s = 1, . . . , S, 0 ≤ t ≤ 1.
Thus, the S posterior samples give rise to an ensemble of AROC curves {AROC(1)(t), . . . ,AROC(S)(t)}, from
which the posterior mean (or median) can be computed
ÂROC(t) =
1
S
S∑
s=1
AROC(s)(t), 0 ≤ t ≤ 1,
with pointwise credible bands derived from the percentiles of the ensemble. In addition, our method also leads
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to closed form expressions for the area and partial area under the AROC curve. It is easy to show that
AAUC(s) =
∫ 1
0
AROC(s)(t)dt = 1−
nD∑
j=1
q
(s)
j U
(s)
Dj ,
pAAUC(s)(t0) =
∫ t0
0
AROC(s)(t)dt = t0 −
nD∑
j=1
q
(s)
j min
{
t0, U
(s)
Dj
}
,
where pAAUC(t0) stands for the partial area under the AROC curve for a pre-specified maximum false positive
fraction of t0. Point and interval estimates for the AAUC and pAAUC are found similarly as for the AROC
curve.
3.2 Model comparison criteria
Since it is ill-advised to compare models based on a single criterion, both the log pseudo marginal likelihood
(LPML) (Geisser and Eddy, 1979) and the widely applicable information criterion (WAIC) (Gelman et al.,
2014; Watanabe, 2010) are employed with a two-fold purpose: i) assist the selection of the number of knots
necessary for adequately modelling FD¯(· | XD¯ = x) and (ii) compare competing models for FD¯(· | XD¯ = x)
(e.g., our B-splines DDP mixture model against a normal linear model).
3.2.1 Log pseudo marginal likelihood (LPML)
The main ingredient to calculate the LPML is the conditional predictive ordinate (CPO). For the ith nondis-
eased observation, the CPOD¯i is defined as
CPOD¯i = f
(
yD¯i | y(−i)D¯
)
=
∫
Θ
f (yD¯i | xD¯i,θ) p
(
θ | y(−i)
D¯
)
dθ, (8)
where θ = (ω1, . . . , ωL,β1, . . . ,βL, σ
2
1, . . . , σ
2
L), y
(−i)
D¯
is yD¯ = (yD¯1, . . . , yD¯nD¯) with the ith observation omitted,
and p
(
θ | y(−i)
D¯
)
is the posterior density of θ based on the data y
(−i)
D¯
. Under the model specification in Section
3 (Step 1), we have
f(yD¯i | xD¯i,θ) =
L∑
l=1
ωlφ
(
yD¯i | z′¯Diβl, σ2l
)
,
where φ(y | µ, σ2) stands for the density function of the normal distribution, evaluated at y, with mean µ and
variance σ2. Thus CPOD¯i is the marginal posterior predictive density of yD¯i given y
(−i)
D¯
and can be interpreted
as the height of this marginal density at yD¯i. A higher value of CPOD¯i under one model for the nondiseased
group implies a better fit of that model for the ith observation, i = 1, . . . , nD¯. Gelfand and Dey (1994) showed
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that CPOD¯i is easily estimated from a posterior sample via
CPOD¯i ≈
{
1
S
S∑
s=1
1
f
(
yD¯i | xD¯i,θ(s)
)}−1 ,
where the result is based on showing that CPOD¯i as defined in (8) can be rewritten as
CPOD¯i =
{∫
Θ
1
f(yD¯i | xD¯i,θ)
p(θ | yD¯)dθ
}−1
=
{
Eθ|yD¯
[
1
f(yD¯i | xD¯i,θ)
]}−1
.
The LPML defined as LPML =
∑nD¯
i=1 log(CPOD¯i) gives an aggregate summary measure of a model’s predictive
ability and the larger the LPML is, the better the fit of the model under consideration.
3.2.2 Widely applicable information criterion (WAIC)
The widely applicable information criterion is decomposed as terms for fit and complexity. The idea is to
compute the log pointwise posterior predictive density (lppd) given by
lppd =
nD¯∑
i=1
logEθ|yD¯ [f(yD¯i | xD¯i,θ)] ≈
nD¯∑
i=1
log
(
1
S
S∑
s=1
f
(
yD¯i | xD¯i,θ(s)
))
,
and then, to adjust for overfitting, add a term to correct for effective number of parameters
ρWAIC =
nD¯∑
i=1
Varθ|yD¯ [log f(yD¯i | xD¯i,θ)]
≈
nD¯∑
i=1
 1S − 1
S∑
s=1
(
log f
(
yD¯i | xD¯i,θ(s)
)
− 1
S
S∑
s=1
log f
(
yD¯i | xD¯i,θ(s)
))2 .
To set the WAIC in the deviance scale, Gelman et al. (2014) suggested to use
WAIC = −2(lppd− ρWAIC),
so that the model that provides the best fit is the one with the smallest WAIC.
4 SIMULATION STUDY
This section reports the results of a simulation study conducted to study the empirical performance of our
nonparametric method for conducting inference about the AROC curve and the AAUC. Extra simulation
results can be found in the Supplementary Materials. All simulations were done in the R environment (version
3.4.4, R Core Team, 2018), using the R-package AROC that accompanies this paper.
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4.1 Simulation Scenarios
We consider a wide range of simulation scenarios, covering cases where covariates do not affect test outcomes
at all, where the performance of the test is affected by covariates but not its discriminatory ability, and cases
where covariates do affect the discriminatory capacity of the test. For the latter case, we consider linear and
nonlinear simple regression models for test outcomes, as well as, multiple regression models. The scenarios we
consider are as follows.
• Scenario I
In this scenario independent data are generated as
yD¯i ∼ N(0.5, 0.52), yDj ∼ N(1, 12), i = 1, . . . , nD¯, j = 1, . . . , nD.
The primary purpose of including this scenario is to investigate the loss of efficiency of using our AROC
estimator, instead of the pooled ROC curve, when covariates have no effect on test outcomes.
• Scenario II
This scenario involves linear mean regression models, namely
yD¯i ∼ N(0.5 + (2xD¯i,1 − 10)/23, 0.52), yDj ∼ N(1 + (2xD¯j,1 − 10)/23, 12).
In this scenario, although covariates do affect test outcomes, they do not affect the discriminatory ability
of the test. As already mentioned, even in this case, the pooled ROC curve can lead to erroneous
inferences, and the AROC curve should be instead reported.
• Scenario III
We consider again linear regression models but, in contrast to Scenario II, now covariates do affect the
discriminatory capacity of the test
yD¯i ∼ N(0.25 + 0.5(2xD¯i,1 − 10)/23, 0.52), yDj ∼ N(0.75 + (2xD¯j,1 − 10)/23, 12).
Scenarios II and III allow us to assess a possible increase in posterior uncertainty of our nonparametric AROC
estimator when a standard normal linear model is the true data generating mechanism. Such popular model
is violated in Scenarios IV–VI.
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• Scenario IV
Data for this scenario are governed by a nonlinear regression model for the nondiseased group and a
linear one for the diseased subjects
yD¯i ∼ N(5 + 3((xD¯i,1 + 8)/23)2 − 25
(
((xD¯i,1 + 8)/23)− 0.2
)3
+
+ 250
(
((xD¯i,1 + 8)/23)− 0.65
)3
+
, 0.52),
yDj ∼ N(−3− 0.6((xDj,1 + 8)/23), 12).
• Scenario V
Here we consider the case where two continuous covariates affect, nonlinearly, the test outcomes in the
nondiseased group, while in the diseased group we specify a simple nonlinear regression model
yD¯i ∼ N(0.5 exp{(2xD¯i,1 − 10)/10)− 2((2x2D¯i,2 − 10)/10), 0.52),
yDj ∼ N(0.5 sin(pi((2xDj,1 − 10)/10 + 1)) + 0.5 exp((2xDj,1 − 10)/10), 12).
• Scenario VI
A nonlinear regression model with an interaction between a continuous and a binary covariate is consid-
ered for the nondiseased group, whereas in the diseased group, as in the previous scenario, we consider
a simple nonlinear regression model
yD¯i ∼ N(− sin(0.7pi((2xD¯i,1 − 10)/10 + 30))xD¯i,3 + (((2xD¯i,1 − 10)/10)2)(1− xD¯i,3), 0.52),
yDj ∼ N(0.5 + (((2xDj,1 − 10)/10)2), 12).
For all scenarios, the continuous covariates x1 and x2, are independently generated from a skew normal
distribution, namely
xD¯i,1, xD¯i,2 ∼ SN(0, 52, 2), xDj,1, xDj,2 ∼ SN(3, 42, 1),
where SN(µ, σ2, λ) denotes a skew normal distribution with mean µ, variance σ2, and skewness parameter
λ. This choice is due to the fact that the covariate distribution in our data application is also skewed (see
Web Figure 4 of the Supplementary Materials). Further, the binary covariate x3 is generated from a Bernoulli
distribution, xD¯i,3 ∼ Bern(0.5).
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4.2 Models
For each simulated dataset, the B-splines DDP mixture model for the conditional distribution of test outcomes
in the nondiseased group was fitted considering four interior knots (K = 4) for each continuous covariate (a
further inspection to this choice is discussed in the next subsection). Following the rule discussed in Section
3 (Step 1), the knots are located at the 0.2, 0.4, 0.6, and 0.8 quantiles of the covariates. Regarding prior
information, α was set equal to one, which according to Hanson (2006) is the default value in the absence
of prior information on the number of components needed to adequately describe FD¯(· | XD¯ = x). Using
results from Antoniak (1974) and Escobar (1994), this choice leads to a prior expected number of components
of approximately of 5 when nD¯ = 50 and 70, and approximately of 6 when nD¯ = 200 and 300. For the total
number of mixture components, we set L = 10, and allow the shrinkage induced by the stick-breaking prior to
adaptively delete redundant components not necessary to characterise the data in the nondiseased group. To
facilitate prior specification of the hyperparameters associated with the centring distribution, responses were
scaled by dividing by the standard deviation when fitting the model. We transformed back to the original scale
when presenting the results. Thus, for the normal-gamma prior, we used m0 = 0Q, S0 = 100IQ, ν = Q + 2,
Ψ−1 = IQ, where IQ denotes the Q×Q identity matrix and we set a = 2 and b = 0.5. The normal prior for βl
is relatively diffuse since the variances in S0 are large, and the degrees of freedom in the Wishart distribution
are small. Note that a = 2 leads to a prior with infinite variance (hence, in some sense, vague) that is centred
around a finite mean (b = 0.5). The prior on σ2, therefore, favours variances less than one; note that the
scaled data have a marginal variance of one, so the within-component variance σ2l is expected to be smaller
than the marginal variance.
We compared our method to results from a Bayesian semiparametric approach where the conditional
distribution for the nondiseased subjects is modelled using a normal linear regression model, that is
FD¯(yD¯i | xD¯i) = Φ(yD¯i | x∗′¯Diβ∗, σ2∗), i = 1, . . . , nD¯,
with x∗′¯
Di
= (1,x′¯
Di
) and β∗ = (β∗0 , β∗1 , . . . , β∗p)′. The cumulative distribution function of UD is modelled, as
in our approach, using the Bayesian bootstrap, so that the two approaches only differ in Step 1. We use the
following priors that align with those from our nonparametric analysis,
β∗ ∼ Np+1(m∗,S∗), σ−2∗ ∼ Γ(a∗, b∗), m∗ ∼ Np+1(m∗0,S∗0), S∗−1 ∼Wp+1(ν∗, (ν∗Ψ∗)−1),
with
m∗0 = 0p+1, S
∗
0 = 100Ip+1, ν
∗ = p+ 3, (Ψ∗)−1 = Ip+1, a∗ = 2, b∗ = 0.5.
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This model can be regarded as the Bayesian counterpart of the frequentist model of Janes and Pepe (2009).
For both Bayesian approaches, 8000 samples were kept after a burn-in period of 2000 iterations of the Gibbs
sampler. We also compared our model to the nonparametric kernel-based method of Rodr´ıguez-A´lvarez et al.
(2011b) (details appear in Web Appendix B of the Supplementary Materials). Estimation in this case relies
on the R-package np (Hayfield and Racine, 2008), and the bandwidth parameters involved were selected using
least-squares cross-validation. Since the kernel approach, as it stands now, can only deal with one continuous
covariate, comparisons with this method were only performed for Scenarios I–IV. As a reinforcement of what
has been exposed in Section 2, we have also computed the pooled ROC curve for all scenarios to assess how
ignoring covariate effect may impact the inferences. We have chosen to estimate the pooled ROC using the
Bayesian bootstrap approach of Gu et al. (2008) which is an extremely robust and computationally simple
one.
4.3 Results
For each of the six scenarios described in Section 4.1, 100 datasets were generated using both balanced and
unbalanced sample sizes, namely (nD¯, nD) = (50, 50), (nD¯, nD) = (200, 70), (nD¯, nD) = (200, 200), and
(nD¯, nD) = (300, 100). The discrepancy between the estimated and true AROC curve was assessed using
the empirical root mean squared error
ERMSE =
√√√√ 1
nT
nT∑
r=1
{
ÂROC(tr)−AROC(tr)
}2 ≈
√∫ 1
0
{
ÂROC(t)−AROC(t)
}2
dt,
where nT = 101 and the tr’s are evenly spaced over [0, 1]. As far as the AAUC is concerned, the behaviour was
evaluated in terms of the bias. Table 1 and Web Table 1 in the Supplementary Materials summarise, respec-
tively, the ERMSE and bias for each scenario, sample size, and approach considered. The estimated AROC
curves along with the 2.5 and 97.5 simulation quantiles for all scenarios and sample size (nD¯, nD) = (200, 200)
are depicted in Figure 2. The plots for the remaining sample sizes are shown in Web Figures 5–10 in the
Supplementary Materials. Our estimator has the ability to successfully recover the form of the true AROC
for all scenarios and samples sizes considered. Even in scenarios where the standard normal linear regression
model holds (Scenarios II and III) our estimator still has an excellent performance, indeed presenting a very
competitive performance with the Bayesian semiparametric estimator where the conditional distribution of
test results for nondiseased subjects is modelled using a normal linear regression model. Further, our Bayesian
nonparametric method presents a superior performance in almost all scenarios and sample sizes, as measured
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by the ERMSE, when compared to its nonparametric competitor, the kernel-based approach. As expected,
posterior uncertainty associated with our estimator decreases as sample size increases. By opposition, the
Bayesian semiparametric estimator is unsuitable for Scenarios IV–VI and its performance fails to improve as
the sample size increases. It is worth commenting that for Scenario I, where the performance of the test is not
affected by covariates at all, our Bayesian nonparametric estimator achieves a smaller ERMSE than that of the
pooled ROC curve, which might seem counterintuitive. However, the fact that we are estimating the pooled
curve by the Bayesian bootstrap where absolutely no structure is imposed, while our estimator in Step 1 still
involves a mixture model (and thus, to a certain extent, a little more structure) might explain the difference.
On the other hand, using the pooled ROC curve when covariates affect test outcomes/discriminatory capacity
of the test, as attested by the results of Scenarios II–VI, generally leads to erroneous inferences.
We have also investigated, in Scenarios I–IV, how the three different approaches estimate the correspond-
ing covariate-specific threshold values used for defining a positive test result, for FPFs of 0.1 and 0.3. The
results are shown in Web Figures 11–14 of the Supplementary Materials. For Scenarios I, II, and III and
for the two FPFs considered, the three approaches were able to recover the true covariate-specific threshold
curve. Whereas our estimates are unbiased but present some larger variability at the boundaries, the kernel
estimates lead to slightly biased estimates. In turn, in Scenario IV, the one involving a nonlinear trend in
the nondiseased group, the Bayesian semiparametric estimates fail to recover the true conditional threshold
curve. Web Appendix C of the Supplementary Materials describes how the covariate-specific thresholds were
computed.
The frequentist coverage of the 95% credible intervals for AROC(t) (averaged over the 101 FPFs con-
sidered), and for the corresponding AAUC are presented in Table 2 and Web Table 2 of the Supplementary
Materials, respectively. For our Bayesian nonparametric estimator, we found the coverages to be between
92 − 99%, showing the validity of our inferences. In turn, for the Bayesian semiparametric approach and for
the scenarios involving nonlinear mean functions, the respective coverage probabilities are, obviously, much
lower.
We rely on the LPML and WAIC discussed in Section 3.2 to assist in: (1) the selection of the number
of knots needed to adequately describe the conditional distribution of test results in the nondiseased group;
and, (2) the comparison between competing models for this distribution, namely our Bayesian B-splines DDP
mixture model against a Bayesian normal linear regression model. Thus, we also investigated the behaviour of
these two criteria in performing the aforementioned two tasks. Specifically, over the 100 simulated datasets, for
each scenario considered and for the different sample sizes in the nondiseased group, nD¯ ∈ {50, 200, 300}, we
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computed the number of times the LPML and WAIC favour the model with four interior knots (K = 4) over
a model with no interior knots (K = 0). Results are displayed in Web Table 3 of the Supplementary Materials
and show that, most of the time, both criteria favour the model with no interior knots for Scenarios I, II, III,
and V, while for Scenarios IV and VI the model with four interior knots is, in general, preferred. Despite this,
our method seems to be robust to the misspecification of the number of knots. This can be observed in Web
Figures 15–20 and Web Tables 5–8 of the Supplementary Materials. In these tables and figures we show, for
the Bayesian nonparametric approach, the comparisons of the simulation results for no interior knots (K = 0)
and four interior knots (K = 4). All in all, the results remain very similar. The major differences are observed
for the estimates of the corresponding covariate-specific threshold values used for defining a positive test result
(Web Figures 21–24). Note that for Scenarios I, II and III, the estimates using no interior knots present lower
variability than those using four interior knots. This is specially remarkable at the boundaries and for small
sample sizes. On the other hand, for Scenario VI (where both criteria favour the model with four interior
knots), the estimates using no interior knots exhibit a large bias at the boundaries. Finally, following the same
reasoning we also checked the percentage of time the LPML and WAIC criteria favour the B-splines DDP
for modelling test outcomes in the nondiseased group over the less flexible Bayesian normal linear regression
model. As our intuition would dictate, with the exception of Scenarios I–III, both the LPML and the WAIC
chose the B-splines DDP mixture model the majority of the time (see Web Tables 4 and 9 for, respectively,
K = 4 and K = 0). Unlike the results on the number of knots, the misspecification of the model, as seen
before, would lead to erroneous inferences.
5 APPLICATION
According to the World Health Organization (WHO), cardiovascular diseases (CVDs) are the leading cause of
death worldwide. Approximately 17.7 million people died from CVD in 2015, with this number representing
31% of worldwide deaths. As can be read at the WHO website (www.who.int/mediacentre/factsheets/fs317/)
“People with cardiovascular disease or who are at high cardiovascular risk (...) need early detection (...)”. In
this work, we are interested in studying the possible modifying effect of age and gender on the discriminatory
capacity of the body mass index (BMI) for detecting the presence of CVD risk factors.
Our data comes from a cross-sectional study carried out by the Galician Endocrinology and Nutrition
Foundation (FENGA). A stratified sampling design was used to obtain a representative sample of the non-
institutionalised civilian population of Galicia (northwest of Spain), consisting of 2840 individuals with an
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age range of 18-85 years (for further details, see Tome´ Mart´ınez de Rituerto et al., 2009). A diseased sub-
ject was defined as any person presenting with two or more CVD risk factors (raised triglycerides, reduced
HDL-cholesterol, raised blood pressure and raised fasting plasma glucose). Based on this definition, out of the
total of 2840 individuals, 691 were classified as diseased (273 women and 418 men) and 2149 as nondiseased
(1250 women and 899 men). As it has been extensively discussed in the literature, anthropometric measures
(as the BMI) perform differently according to both age and gender. This can be observed in Web Table 10
of the Supplementary Materials, where some summary statistics of the data are presented. As a result, it
is expected that the discriminatory capacity of the BMI varies with age and gender. This is confirmed by
Figure 3(a), which shows, separately for men and women, the estimated age-specific AUCs obtained using
the Bayesian nonparametric approach of Ina´cio de Carvalho et al. (2013). Similar results have been reported
in Rodr´ıguez-A´lvarez et al. (2011b) and Rodr´ıguez-A´lvarez et al. (2011a). Note that whereas for men the
discriminatory capacity of the BMI remains more or less constant along age, for women, age displays a marked
effect, with accuracy decreasing until an age of about 70 years old, and then slightly increasing until the age
of 80. Nonetheless, even for men, the estimated AUC obtained by pooling the data (separately in men and
women) without regard to age is, in general, larger than the age-specific AUC (see Figure 3(a) and Table 3).
As a consequence, analyses based upon the pooled ROC curve would lead to optimistic conclusions about the
discriminatory capacity of the BMI when predicting the presence of CVD factors in both men and women. As
discussed in Section 2, this optimism (bias) is because, for the pooled ROC curve, a common threshold value
is used for all individuals regardless of their covariate values. In particular, in our study, CVD risk factors are
more prevalent in old individuals, where the BMI is also higher. It implies that the pooled ROC curve for the
BMI in both men and women ‘incorporates’ the capacity of distinguishing between diseased and nondiseased
individuals attributable to age.
In line with the above-discussed results, we started by estimating the age-adjusted ROC curve (AROC)
separately in men and women using our proposed Bayesian nonparametric estimator. Results were also com-
pared to the ones obtained by using the Bayesian semiparametric and kernel methods described in Section
4. For our proposal, we modelled age effects using a B-spline basis of dimension 3, thus corresponding to
no interior knots; the selection of the basis dimension was done by the LPML and WAIC (results shown in
Web Table 11 of the Supplementary Materials). For both Bayesian approaches, posterior inference was based
on 45000 Gibbs sampler iterates after a burn-in of the first 5000 realisations was discarded and the same
prior specification described in Section 4 was applied. Inspection of traceplots and Geweke criterion suggest
convergence of the chains. The estimated AROC curves are shown in Figure 3(b), where we also depict the
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pooled ROC curves (estimated as described in Section 4 and separately for men and women). As expected,
all approaches provided an AROC curve that lies below the corresponding pooled ROC curve, with this being
especially remarkable in women. These results highlight the need for including covariate information into the
ROC analysis and the danger that focusing on the pooled ROC curve may cause. Although the estimated
AROC curves under our Bayesian nonparametric model and the kernel-based approach are very similar, the
differences to the results obtained under the Bayesian semiparametric method are quite pronounced in women.
It is worth remembering that the only difference between our Bayesian nonparametric model and the semi-
parametric one is how the conditional cumulative distribution function of test outcomes in the nondiseased
group is modelled. Specifically, under our proposal, such distribution is modelled through a B-splines DDP
mixture model, whereas under the semiparametric approach it is done via a Bayesian normal linear model (as
detailed in Section 4). Both the LPML and WAIC criteria support the use of our flexible B-splines DDP for
modelling the distribution of test results in the nondiseased group over the more restrictive Bayesian normal
linear model (results not shown). Recall that, as the AROC is an average of covariate-specific ROC curves, the
AAUC is also an average of covariate-specific AUCs. This is patent in Figure 3(a) where we present, separately
for men and women, the age-specific AUCs along with the pooled AUC and the area under the age-adjusted
ROC curve (AAUC) estimated using our approach.
Thus far, AROC estimates were obtained separately for men and women. We now jointly analyse the
whole sample, with interest lying in estimating a single AROC curve by adjusting for both age and gender.
This will provide us with a global summary of the age- and gender-specific accuracy of the BMI to detect
clusters of CVD. Estimation was carried out using the proposed Bayesian nonparametric estimator and the
Bayesian semiparametric one. The results shown above suggest the presence of an interaction between age
and gender, which was included in both models. The kernel-based approach, as it stands now, can only deal
with one continuous covariate, and therefore cannot be applied in this setting. AROC estimates are shown in
Figure 4(a). The AAUC under our Bayesian nonparametric approach is 0.667 (0.639, 0.695), thus revealing a
reasonable overall age- and gender-specific accuracy of the BMI to predict CVD. Again, the estimated AROC
curve lies below the pooled ROC curve (estimated with the whole sample), with the pooled AUC being 0.766
(0.747, 0.783). Here, the pooled ROC curve ‘incorporates’ the capacity of distinguishing between diseased and
nondiseased individuals attributable to both age and gender. For this joint analyses setting, as it was also
the case for the separate analyses in men and women, both the LPML and WAIC criteria favour the use of
our B-splines DDP for modelling the test outcomes in the nondiseased group over the normal linear model.
Particularly, the LPML is −5868 for our approach and −6058 for the normal linear competitor. A deeper in-
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spection was done via a plot of the log CPO ratio of the B-splines DDP mixture model over the normal linear
model against observation numbers. Thus, a point larger than 0 supports our approach. Results are displayed
in Figure 5(c) and it shows that approximately 66% of the observations support our model. The superiority
of our method was further validated by the WAIC, which was 11736 under our approach and 12117 under the
normal linear model. Since the LPML and WAIC are relative criteria, posterior predictive checks were also
implemented. We generated replicate datasets from the posterior predictive distribution in the nondiseased
group and compared to the data (BMI values) in such group using specific test quantities. For the choice
of the test quantities, we follow Gabry et al. (2017), who suggest choosing statistics that are orthogonal to
the model parameters. Since we are using a location-scale mixture, we decided to investigate how well the
posterior predictive distribution captures the skewness and kurtosis. From Figures 5(a) and 5(b) we see that
our model does an excellent job capturing both quantities, while the normal linear model fails. Also shown in
Figure 5 are the kernel density estimates of 500 randomly selected datasets drawn from the posterior predictive
distribution (nondiseased group) compared to the kernel density estimate of the BMI in the nondiseased group.
It is evident that our model, as opposed to the normal linear model, is able to simulate data that is very much
similar to the observed BMI values. Further, although the difference between the estimated AROCs by our
approach and the Bayesian semiparametric method is not large, the estimated threshold values used to classify
an individual as testing positive, shown in Figure 4(b) for a FPF of 0.3, differ by a large extent. This is also
in line with what has been discussed in the simulation study presented in Section 4.
Finally, a sensitivity analysis to our prior specification, for the model fitted in the nondiseased group, was
conducted. The three prior configurations considered are catalogued in Web Table 12 of the Supplementary
Materials. The first and second prior configurations changed α, the parameter that controls the number of
mixture components, and L, the upper bound on the number of mixture components. Specifically, the first
configuration decreased α from 1 to 0.1 and increased L from 10 to 30, whereas for the second configuration,
α was increased from 1 to 10 and L was again set to 30. In turn, the third configuration, changed the within-
component variance parameters from a = 2 and b = 0.5 to a = 2 and b = 3; this new configuration leads to
larger within-component variances. The AAUC results for each of the three configurations are, respectively,
0.666 (0.638, 0.693), 0.663 (0.636, 0.690), and 0.667 (0.638, 0.696), which show that inferences are essentially
unchanged, partially due, possibly, to the large sample size (2149 nondiseased individuals).
22
6 CONCLUDING REMARKS
We developed a Bayesian nonparametric regression model to estimate the covariate-adjusted ROC curve.
The flexibility of our model arises from using B-splines dependent Dirichlet process mixtures and the Bayesian
bootstrap. Under our model framework, and by opposition to the existing nonparametric kernel-based method,
continuous and categorical covariates, as well as, interactions, can be easily handled. The model developed
has thus the potential to be applicable to many populations, as well as, for a large number of diseases and
(continuous) medical tests. Our simulation study illustrated the ability of the model to respond to complex
data distributions in a variety of scenarios, with little price to be paid in terms of decreased posterior precision
for the extra generality of our nonparametric estimator when compared with parametric estimates (even when
the parametric model holds). Further, when compared to the kernel method, the general superiority of our
method, as measured by the empirical root mean squared error between estimated and true covariate-adjusted
ROC curves, was also evident in the simulation study. Additionally, the frequentist validity of our inferences,
in terms of coverage probability, was also demonstrated. Our data application revealed a reasonable overall
age- and gender-specific accuracy of the BMI to predict CVD and also how erroneous conclusions can be if
focus is placed on the pooled ROC curve instead of on covariate-adjusted measures. The B-splines dependent
Dirichlet process mixture model used for the conditional distribution of test outcomes in the nondiseased group
assumes a known number of knots and model selection criteria (LPML and WAIC) were used to choose between
candidate models with different number of knots. Although a prior can be placed on the number of knots
and their location (DiMatteo et al., 2001), this could be computationally difficult to implement efficiently in
practice (e.g., involving reversible jump Markov chain Monte Carlo). A viable alternative is to use penalised
splines (Eilers and Marx, 1996), thus leading to a penalised splines dependent Dirichlet process mixture model
that is, in essence, a dependent Dirichlet process mixture of generalised additive models. Another interesting
avenue for future research is the development of AROC estimators based on direct ROC regression methodology
(Pepe, 2000).
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A APPENDIX
Result
Suppose that, for all x, the covariate-specific ROC curve, ROC(· | x), is concave and the distribution of the
covariates is the same in the healthy and diseased groups, i.e, HD¯(x) = HD(x). Then,
AROC(t) ≥ ROC(t) for all t ∈ [0, 1].
A similar result has been proved in Pepe (2003, Chapter 6) and Janes and Pepe (2008b), but under the more
restrictive assumption that the covariate-specific ROC curve is the same across all covariate values. This
assumption is relaxed here.
Proof. Using the notation of Section 2, we have
AROC(t) =
∫
ROC(t | x)dHD(x)
=
∫
ROC
(∫
txdHD¯(x)
∣∣∣∣ x) dHD(x)
≥
∫ ∫
ROC(tx | x)dHD¯(x)dHD(x)
=
∫ ∫
ROC(tx | x)dHD(x)dHD¯(x)
=
∫
ROC(t)dHD¯(x)
= ROC(t),
where the inequality follows from the concavity of the covariate-specific ROC curves (using Jensen’s inequality).
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Figure 1: For a hypothetical diagnostic test Y , comparisons among the pooled ROC curve (black solid line),
the AROC curve (red dashed line) and the covariate-specific ROC curve (grey solid lines) in the presence of a
continuous covariate X. (a) The covariate is not associated with the diagnostic test outcome (YD¯ ∼ N(0.5, 0.32)
and YD ∼ N(1, 0.32)). (b) The covariate is associated with the diagnostic test outcome, but it has no impact
on the diagnostic accuracy of the test (YD¯ ∼ N(0.5+XD¯, 0.32) and YD ∼ N(0.75+XD, 0.32)). (c) The same as
in (b) but the covariate has an impact on the diagnostic accuracy of the test (YD¯ ∼ N(0.25 + 0.5XD¯, 0.32) and
YD ∼ N(0.75 +XD, 0.32)). The left-hand side plots in (b) and (c) show the situation where the distribution of
the covariate is the same in the healthy and diseased group (XD¯ ∼ N(0, 0.152) and XD ∼ N(0, 0.152)). The
middle- and right-hand side plots in (b) and (c) depict the situation where the distribution of the covariate is
different in the healthy and diseased group. Specifically, in the middle-hand side plots XD¯ ∼ N(0, 0.152) and
XD ∼ N(0.4, 0.152); and in the right-hand side plots XD¯ ∼ N(0.4, 0.152) and XD ∼ N(0, 0.152).
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Table 1: Average (standard deviation) (× 100), across simulations, of the empirical root mean squared error
for the different approaches under consideration and for K = 4. The results are presented for each of the
simulated scenarios and sample sizes.
Sample size
(nD¯, nD)
Scenario Approach (50, 50) (200, 70) (200, 200) (300, 100)
I
Bayesian nonparametric 6.013 (3.494) 4.438 (2.296) 3.174 (1.644) 4.070 (2.121)
Bayesian semiparametric 6.345 (3.483) 4.465 (2.260) 3.163 (1.548) 4.195 (2.122)
Kernel 8.210 (2.964) 5.363 (2.057) 4.216 (1.305) 4.937 (1.897)
Pooled 7.233 (2.928) 5.123 (2.108) 4.006 (1.283) 4.752 (1.875)
II
Bayesian nonparametric 5.990 (3.498) 4.434 (2.293) 3.164 (1.630) 4.071 (2.124)
Bayesian semiparametric 6.328 (3.484) 4.449 (2.257) 3.167 (1.545) 4.194 (2.114)
Kernel 8.363 (3.107) 5.448 (2.151) 4.425 (1.459) 5.015 (2.054)
Pooled 7.740 (3.208) 5.722 (2.552) 5.240 (1.891) 5.807 (2.551)
III
Bayesian nonparametric 6.021 (3.454) 4.405 (2.324) 3.196 (1.592) 4.118 (2.133)
Bayesian semiparametric 6.177 (3.431) 4.433 (2.274) 3.206 (1.498) 4.206 (2.149)
Kernel 8.127 (2.954) 5.398 (2.179) 4.408 (1.354) 5.023 (2.052)
Pooled 7.216 (2.949) 5.251 (2.344) 4.395 (1.630) 5.083 (2.284)
IV
Bayesian nonparametric 6.060 (3.249) 3.973 (2.288) 2.914 (1.539) 3.888 (2.085)
Bayesian semiparametric 8.424 (4.373) 8.271 (4.228) 7.817 (4.042) 8.837 (4.035)
Kernel 8.475 (2.482) 6.548 (1.891) 5.794 (1.351) 6.198 (1.684)
Pooled 16.571 (2.100) 16.450 (1.723) 16.497 (1.194) 16.654 (1.259)
V
Bayesian nonparametric 6.361 (2.832) 5.553 (1.944) 4.394 (1.316) 4.646 (1.396)
Bayesian semiparametric 15.745 (3.610) 17.277 (2.731) 17.058 (2.270) 17.311 (2.073)
Kernel - - - -
Pooled 11.203 (2.281) 10.468 (1.448) 9.889 (1.183) 9.840 (1.228)
VI
Bayesian nonparametric 5.673 (3.056) 4.304 (2.180) 3.063 (1.748) 3.781 (2.120)
Bayesian semiparametric 8.674 (4.397) 8.948 (2.880) 8.104 (2.471) 8.442 (2.805)
Kernel - - - -
Pooled 12.063 (3.627) 11.749 (3.125) 11.086 (2.240) 11.143 (2.485)
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Figure 2: True (solid black line) and average value of 100 simulated datasets (dashed lines) of the posterior
mean (for the Bayesian estimators) of the covariate adjusted ROC curve/pooled ROC curve for each of the
scenarios and sample size (nD¯, nD) = (200, 200). The shaded area are bands constructed using the pointwise
2.5% and 97.5% quantiles across simulations.
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Table 2: 95% coverage probabilities for the AROC (average over all FPFs) for the different approaches under
consideration and for K = 4. The results are presented for each of the simulated scenarios and sample sizes.
Sample size
(nD¯, nD)
Scenario Approach (50, 50) (200, 70) (200, 200) (300, 100)
I
Bayesian nonparametric 96.0 95.0 95.0 95.0
Bayesian semiparametric 93.0 95.0 94.0 94.0
II
Bayesian nonparametric 96.0 96.0 94.0 95.0
Bayesian semiparametric 93.0 95.0 94.0 94.0
III
Bayesian nonparametric 96.0 95.0 95.0 94.0
Bayesian semiparametric 94.0 95.0 95.0 94.0
IV
Bayesian nonparametric 96.0 96.0 93.0 93.0
Bayesian semiparametric 81.0 70.0 52.0 55.0
V
Bayesian nonparametric 97.0 95.0 95.0 96.0
Bayesian semiparametric 55.0 35.0 27.0 28.0
VI
Bayesian nonparametric 98.0 97.0 96.0 95.0
Bayesian semiparametric 87.0 77.0 60.0 68.0
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(a) Age-specific AUC
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Figure 3: Top row: Age-specific AUC: posterior mean (black line) and 95% pointwise credible band (grey area) for women
(left) and men (right). The red line corresponds to the estimated pooled AUC and the blue line to the estimated area under the
age-adjusted ROC curve (AAUC). Bottom row: estimated age-adjusted ROC curve (AROC) and 95% intervals obtained under our
Bayesian nonparametric estimator, the Bayesian semiparametric method and the kernel-based approach. In all cases, the analyses
were done separately in women and men with age as the single covariate to adjust for. For comparison purposes, the estimated
pooled ROC curves are also depicted.
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Figure 4: (a) Age/gender-adjusted ROC curves (AROC): posterior means and 95% pointwise credible bands under our Bayesian
nonparametric estimator and the Bayesian semiparametric estimator. In both cases, the analyses were done including the age-by-
gender interaction. For comparison purposes, the estimated pooled ROC based on the global sample is also depicted. (b) Posterior
mean and 95% pointwise credible band of the AROC-based threshold values along age for women and men, for a FPF = 0.3.
34
05000
10000
15000
20000
0 1 2 3
Statistic
Fr
eq
ue
nc
y
Skewness
0
10000
20000
30000
10 20 30
Statistic
Fr
eq
ue
nc
y
Kurtosis
0.00
0.05
0.10
0.15
10 20 30 40 50
BMI
D
en
si
ty
(a) Predictive checks: Bayesian nonparametric model (B-splines DDP)
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(b) Predictive checks: Bayesian normal-linear model
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Figure 5: Posterior predictive checks. Histograms of statistics skewness and kurtosis computed from 45000 draws from the pos-
terior predictive distribution in the nondiseased group. The red line is the estimated statistic from the observed BMI (nondiseased
group). The right-hand side plots show the kernel density estimate of the observed BMI (solid black line), jointly with the kernel
density estimates for 500 simulated datasets drawn from the posterior predictive distribution. Shown in (c) is the logarithm of the
ratio of the CPO from the Bayesian nonparametric approach to the CPO from the Bayesian normal linear model. In all cases the
results are for the analyses including the age-by-gender interaction.
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Global Gender
sample Female Male
Pooled AUC 0.766 (0.747, 0.783) 0.800 (0.772, 0.826) 0.725 (0.696, 0.751)
AAUC 0.667 (0.639, 0.695) 0.684 (0.642, 0.724) 0.661 (0.624, 0.696)
Table 3: Estimated areas under the pooled (AUC) and AROC (AAUC) curves jointly with 95% credible intervals. The pooled
AUCs were estimated using the global sample and in men and women separately. The AAUCs were estimated on the basis of
our Bayesian nonparametric estimator. For the global sample, the AAUC was estimated incorporating into the B-splines DDP
mixture model the age-by-gender interaction. For the results in men and women, the analyses were done separately in each group
with age as the single covariate.
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Supplementary materials for “Bayesian nonparametric inference for the
covariate-adjusted ROC curve”
Vanda Ina´cio de Carvalho and Mar´ıa Xose´ Rodr´ıguez-A´lvarez
This document contains supplementary materials to the paper “Bayesian nonparametric inference for the
covariate-adjusted ROC curve”. In Web Appendix A the complete Gibbs sampler used to fit our B-splines
DDP mixture model for the conditional distribution of test outcomes in the nondiseased group is reported.
Web Appendix B describes the details of the kernel-based estimator for the AROC proposed by Rodr´ıguez-
A´lvarez et al. (2011). In Web Appendix C we describe the computation of covariate-specific threshold values
based on the B-splines DDP mixture model. In Web Appendix D we present a brief usage description of the
AROC package that accompanies this paper. Supporting figures and tables for the simulation study discussed
in Section 4 of the main document are provided in Web Appendix E. Specifically, in Web Appendix E.1 we
show the results when the B-splines DDP mixture model was fitted considering four interior knots (K = 4),
and in and Web Appendix E.2 the comparisons between the results using four interior knots (K = 4) and no
interior knots (K = 0). Finally, Web Appendix F contains extra results for the real data application described
in Section 5 of the main document.
Vanda Ina´cio de Carvalho, School of Mathematics, University of Edinburgh, Scotland, UK (Vanda.Inacio@ed.ac.uk). Mar´ıa
Xose´ Rodr´ıguez-A´lvarez, BCAM-Basque Center for Applied Mathematics & IKERBASQUE, Basque Foundation for Science,
Bilbao, Basque Country, Spain (mxrodriguez@bcamath.org).
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Web Appendix A BLOCKED GIBBS SAMPLER ALGORITHM
We report the complete Gibbs sampler used to fit our B-splines DDP mixture model for FD¯(·|XD¯|x), which
is essentially a covariate-dependent version of the Blocked Gibbs sampler algorithm in Ishwaran and James
(2001). We use configuration variables to identify the label of the mixture component to which the ith
nondiseased subject belongs to. Let Si = l denotes that the ith nondiseased subject is allocated to component
l, i = 1, . . . , nD¯, l = 1, . . . , L. The Gibbs sampling procedure alternates through the following steps.
Step 1: Update Si, for i = 1, . . . , nD¯, by sampling from its full conditional distribution, which is a multinomial
distribution with probabilities
Pr(Si = l | else) =
ωlφ(yD¯i | z′¯Diβl, σ2l )∑L
k=1 ωkφ(yD¯i | z′¯Diβk, σ2k)
, ωl = vl
∏
r<l
(1− vr), l = 1, . . . , L.
Step 2: Update the stick-breaking weights from their conjugate beta posterior distribution
vl | else ∼ Beta
(
nl + 1, α+
L∑
r=l+1
nr
)
, l = 1, . . . , L− 1,
with nl =
∑nD¯
i=1 I(Si = l) being the number of observations from component l.
Step 3: Update the component specific parameters, βl and σ
2
l (l = 1, . . . , L), as in a standard Bayesian
normal linear regression model, using observations from component l, i.e.,
βl | else ∼ NQ
Vl
S−1m+ σ−2l ∑
{i:Si=l}
zD¯iyD¯i
 ,Vl
 , Vl =
S−1 + σ−2l ∑
{i:Si=l}
zD¯iz
′¯
Di
−1 ,
σ−2l | else ∼ Γ
a+ nl
2
, b+
1
2
∑
{i:Si=l}
(
yD¯i − z′¯Diβl
)2 .
Step 4: Update the hyperparameters, m and S, by sampling from their full conditional distributions, namely
m | else ∼ NQ
(
V
(
S−10 m0 + S
−1
L∑
l=1
βl
)
,V
)
, V = (S−10 + LS
−1)−1,
S−1 | else ∼WQ
ν + L,(νΨ + L∑
l=1
(βl −m)(βl −m)′
)−1 .
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Web Appendix B DETAILS ON THE KERNEL APPROACH OF Rodr´ıguez-A´lvarez et al.
(2011)
We start by assuming that we have random samples {(yD¯i, xD¯i)}nD¯i=1 and {(yDj , xDj)}nDj=1 and that test outcomes
in the nondiseased group are modelled through a location-scale regression model
YD¯ = µD¯(XD¯) + σD¯(XD¯)εD¯.
Here µD¯ is the regression function, σ
2
D¯
is the variance function, and εD¯ has zero mean, variance one, and
distribution function FεD¯ . Both the regression and variance functions are estimated using local estimators,
particularly, using Nadaraya–Watson estimators (Fan and Gijbels, 1996, Chapter 2). Once we have estimates
of the mean and variance functions, which we denote by µ̂D¯ and σ̂
2
D¯
, we can compute the standardised residuals
and estimate their distribution through the empirical distribution function, i.e.,
ε̂D¯i =
yD¯i − µ̂D¯(xD¯i)
σ̂D¯(xD¯i)
, F̂εD¯(y) =
1
nD¯
nD¯∑
i=1
I{ε̂D¯i ≤ y}.
Then, we can model UDj as
UDj = 1− F̂εD¯
(
yDj − µ̂D¯(xDj)
σ̂D¯(xDj)
)
, j = 1, . . . , nD,
and therefore, the AROC curve is estimated as
ÂROC(t) =
1
nD
nD∑
j=1
I
{
1− F̂εD¯
(
yDj − µ̂D¯(xDj)
σ̂D¯(xDj)
)
≤ t
}
, 0 ≤ t ≤ 1.
Uncertainty estimation is done via the bootstrap (Davison and Hinkley, 1997), and the scheme we present relies
on a combination of a bootstrap of the residuals in the nondiseased group and a resampling cases approach in
the diseased group. Let B denotes the number of resamples; the algorithm is as follows.
Step 1: In the nondiseased group sample with replacement from the standardised residuals (ε̂D¯1, . . . , ε̂D¯nD¯)
to form bootstrap samples (ε̂
(b)
D¯1
, . . . , ε̂
(b)
D¯nD¯
), then obtaining
y
(b)
D¯i
= µ̂D¯(xD¯i) + σ̂D¯(xD¯i)ε̂
(b)
D¯i
, b = 1, . . . , B,
where µ̂ and σ̂ are the estimates based on the original sample. Our bootstrap samples in the nondis-
eased group are thus of the form {(y(b)
D¯1
, xD¯1), . . . , (y
(b)
D¯nD¯
, xD¯nD¯)}. Based on these samples, estimate the
mean and variance functions, respectively denoted by µ̂
(b)
D¯
and σ̂
2(b)
D¯
, compute the standardised residuals
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ε̂
∗(b)
D¯i
= (yD¯i − µ(b)D¯ (xD¯i))/σ
(b)
D¯
(xD¯i), and denote the empirical distribution function of these by F̂
(b)
εD¯ . The
use of this bootstrap is due to the well-known result of Hardle and Marron (1991, p. 781) that for non-
parametric regression, bootstrapping the original data is not a valid approach and an approach based on
bootstrapping the residuals should be preferred.
Step 2: In the diseased group, bootstrap samples {(y(b)D1, x(b)D1), . . . , (y(b)DnD , x
(b)
DnD
)} are obtained by resampling,
with replacement, from the original diseased sample–resampling cases bootstrap. Note that Steps 1 and
2 are interchangeable.
Step 3: Compute
U
(b)
Dj = 1− F̂ (b)εD¯
y(b)Dj − µ̂(b)D¯ (x(b)Dj)
σ̂
(b)
D¯
(x
(b)
Dj)
 ,
and then compute the corresponding AROC curve
ÂROC
(b)
(t) =
1
nD
nD∑
j=1
I
{
U
(b)
Dj ≤ t
}
, 0 ≤ t ≤ 1.
Once this process has been completed, and according to the percentile method, a bootstrap confidence
interval for AROC(t) of confidence level 1−α is given by the quantiles α/2 and 1−α/2 of the ensemble(
ÂROC
(1)
(t), . . . , ÂROC
(B)
(t)
)
.
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Web Appendix C COMPUTATION OF THE COVARIATE-SPECIFIC THRESHOLD VAL-
UES
Let x = (x1, . . . , xp) be the vector of covariates for which we are interested in computing the threshold value,
cx, that gives rise to a FPF of t. From step 1 of our modelling procedure described in Section 3.1 of the main
paper, we can easily compute
c
(s)
x = F
−1(s)
D¯
(1− t | XD¯ = x), 0 ≤ t ≤ 1, (C1)
where
F
(s)
D¯
(1− t | XD¯ = x) =
L∑
l=1
ω
(s)
l Φ
(
1− t | z′β(s),
(
σ
(s)
l
)2)
, s = 1, . . . , S,
with z′ =
(
1,B′ξ1(x1), . . . ,B
′
ξp
(xp)
)
and S denotes the number of posterior samples after burn-in. Note that
the inversion in (C1) is done numerically. The S posterior samples originate an ensemble of optimal thresholds(
c
(1)
x , . . . , c
(S)
x
)
from which the posterior mean can be computed
cˆx =
1
S
S∑
s=1
c
(s)
x ,
with credible intervals derived from the percentiles of the ensemble.
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Web Appendix D AROC PACKAGE
This section contains a brief description of the R-package we developed to accompany this paper. The pack-
age can be freely downloaded from https://CRAN.R-project.org/package=AROC, where a more detailed
explanation of its use can be found. The package implements four different methods for the estimation of
the covariate-adjusted ROC (AROC) curve, and two methods for the estimation of the pooled ROC curve.
Specifically, the implemented methods and associated R-functions are:
• AROC.bnp: Estimates the AROC curve (and AAUC/pAAUC) using our proposed Bayesian nonparametric
approach.
• AROC.bsp: Estimates the AROC curve (and AAUC/pAAUC) using the Bayesian semiparametric ap-
proach discussed in Section 4 of the main document.
• AROC.kernel: Estimates the AROC curve (and AAUC) using the nonparametric kernel-based method
proposed by Rodr´ıguez-A´lvarez et al. (2011). The method, as it stands now, can only deal with one
continuous covariate.
• AROC.sp: Estimates the AROC curve (and AAUC) using the semiparametric approach proposed by
Janes and Pepe (2009).
• pooledROC.BB: Estimates the pooled ROC curve (and AUC) using the Bayesian bootstrap estimator
proposed by Gu et al. (2008).
• pooledROC.emp: Estimates the pooled ROC curve (and AUC) using the empirical estimator proposed
by Hsieh and Turnbull (1996).
In all cases, numerical and graphical summaries can be obtained by calling the functions print, summary
and plot. In addition, and for the four methods that estimate the AROC, the package provides func-
tions for estimating the associated AROC-based threshold values (functions compute.threshold.AROC.bnp,
compute.threshold.AROC.bsp, compute.threshold.AROC.kernel and compute.threshold.AROC.sp). Fi-
nally, for the Bayesian approaches, it is also possible to conduct posterior predictive checks by means of the
functions predictive.checks.AROC.bnp and predictive.checks.AROC.bsp. A detailed description of each
function and the input arguments they require can be found in the documentation files of the package, where
usage examples are also provided.
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By way of example, and since we are not allowed to make the endocrine dataset publicly available, we
present here the syntax for the CARET PSA data discussed in Etzioni et al. (1999). The dataset contains
71 cases of prostate cancer and 71 age- and serum samples- matched controls (nondiseased individuals) who
participated in a lung cancer prevention trial (CARET, Beta-carotene and retinol trial). For each subject
on the study, serum samples were drawn at baseline and at two-year intervals after that. All the cases
(and thus the matched controls) have, at least, three and up to eight serum samples. The aim here is to
determine if the free prostate specific antigen (PSA) is able to discriminate cases from controls, adjusting
for age. It has been reported (see Pepe, 2003, pp 163) that age does not modify (have an effect on) the
accuracy of the free PSA when discriminating between cases and controls. Age is, however, associated with
PSA values. The older the individual, the larger the free PSA values. As extensively discussed in Section 2
of the main paper, even in these cases the age-specific ROC curve (which is the same for all ages) may not
coincide with the pooled ROC curve. It does coincide, however, with the age-adjusted ROC curve. Also, in
a matched study (as this one), the pooled (unadjusted) ROC curve also has a difficult interpretation: since
the sample of control individuals is artificially constructed, the FPF axis of the pooled ROC curve does not
represent the FPF of the diagnostic test in the real population. In contrast, the FPF axis of the AROC
describes the real-world performance of the diagnostic test in a population with fixed covariate value (see
Janes and Pepe, 2008, for a detailed discussion). For a simple illustration of the usage of the package, in
the subsequent analyses we only consider the last PSA measurement of each subject. The PSA dataset can
be found in https://research.fhcrc.org/diagnostic-biomarkers-center/en/datasets.html, and it has
been included in the R-package AROC. Here there is a brief summary of the data
sessionInfo()
## R version 3.4.4 (2018-03-15)
## Platform: x86_64-pc-linux-gnu (64-bit)
## Running under: Ubuntu 16.04.4 LTS
##
## Matrix products: default
## BLAS: /usr/lib/libblas/libblas.so.3.6.0
## LAPACK: /usr/lib/lapack/liblapack.so.3.6.0
##
## locale:
## [1] LC_CTYPE=en_US.UTF-8 LC_NUMERIC=C
## [3] LC_TIME=es_ES.UTF-8 LC_COLLATE=en_US.UTF-8
## [5] LC_MONETARY=es_ES.UTF-8 LC_MESSAGES=en_US.UTF-8
## [7] LC_PAPER=es_ES.UTF-8 LC_NAME=C
## [9] LC_ADDRESS=C LC_TELEPHONE=C
## [11] LC_MEASUREMENT=es_ES.UTF-8 LC_IDENTIFICATION=C
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##
## attached base packages:
## [1] stats graphics grDevices utils datasets methods base
##
## other attached packages:
## [1] knitr_1.20
##
## loaded via a namespace (and not attached):
## [1] compiler_3.4.4 magrittr_1.5 tools_3.4.4 stringi_1.2.2
## [5] stringr_1.3.0 evaluate_0.10.1 tcltk_3.4.4
library(AROC)
data(psa)
summary(psa)
## id marker1 marker2 status
## Min. : 1.00 Min. : 0.030 Min. :0.0000 Min. :0.0000
## 1st Qu.: 39.00 1st Qu.: 1.050 1st Qu.:0.1588 1st Qu.:0.0000
## Median : 73.00 Median : 1.800 Median :0.2124 Median :0.0000
## Mean : 72.69 Mean : 4.803 Mean :0.2200 Mean :0.3353
## 3rd Qu.:107.00 3rd Qu.: 3.960 3rd Qu.:0.2732 3rd Qu.:1.0000
## Max. :141.00 Max. :99.980 Max. :1.0003 Max. :1.0000
## age t
## Min. :46.75 Min. :-9.0080
## 1st Qu.:61.07 1st Qu.:-3.7290
## Median :65.16 Median :-1.4210
## Mean :64.86 Mean :-1.3714
## 3rd Qu.:69.00 3rd Qu.: 0.8255
## Max. :80.83 Max. : 7.4200
The dataset contains the patient identifier (id), the free PSA (variable marker1) and total PSA (variable
marlker2), the variable that indicates the presence/absence of prostate cancer (status), the age at which the
serum samples were drawn (variable age), and the time (in years) relative to prostate cancer diagnosis (t).
For our analyses, we focus on the last measurement, and the free PSA is log-transformed
# Select the last measurement
newpsa <- psa[!duplicated(psa$id, fromLast = TRUE),]
# Log-transform the biomarker
newpsa$l_marker1 <- log(newpsa$marker1)
We start our analyses by estimating the pooled ROC curve using the Bayesian bootstrap estimator proposed
Gu et al. (2008)
set.seed(123) # for reproducibility
psa_pooled <- pooledROC.BB(y0 = newpsa$l_marker1[newpsa$status == 0],
y1 = newpsa$l_marker1[newpsa$status == 1],
p = seq(0,1,l=101), B = 5000)
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Through y0 and y1 arguments, the user specifies the vector of diagnostic test outcomes in, respectively, the
nondiseased and diseased groups. The set of FPFs at which to estimate the pooled ROC curve is specified in
p, and argument B allows to indicate the the number of Bayesian bootstrap resamples. A numerical summary
of the fitted model can be obtained by calling the function summary, that provides, among other things, the
estimated area under pooled ROC curve (AUC) and 95% credible intervals
summary(psa_pooled)
##
## Call:
## pooledROC.BB(y0 = newpsa$l_marker1[newpsa$status == 0], y1 = newpsa$l_marker1[newpsa$status ==
## 1], p = seq(0, 1, l = 101), B = 5000)
##
## Approach: Pooled ROC curve - Bayesian bootstrap
## ----------------------------------------------
## Area under the pooled ROC curve: 0.878 (0.815, 0.928)
To complement those numerical results, the AROC package furnishes graphical results that can be used to
further explore the fitted model. Specifically, the function plot depicts the estimated pooled ROC curve and
AUC, jointly with 95% credible intervals
plot(psa_pooled)
The result of the above code is shown in Web Figures 1(a). We now turn our attention to the estimation of
the age-ajusted ROC curve (AROC) using the Bayesian nonparametric approach proposed in this paper. The
code for the PSA data is as follows
set.seed(123) # for reproducibility
psa_aroc_bnp <- AROC.bnp(formula.healthy = l_marker1 ~ f(age, K = 0),
group = "status", tag.healthy = 0, data = newpsa, scale = TRUE,
p = seq(0,1,l=101), compute.lpml = TRUE, compute.WAIC = TRUE,
m0 = rep(0,4), S0 = 100*diag(4), nu = 6, Psi = diag(4),
a = 2, b = 0.5, L = 10, nsim = 50000,nburn = 5000)
The argument formula.healthy is a formula object specifying the B-splines DDP mixture of normals
model for estimation of the conditional distribution function of the diagnostic test outcomes in the nondis-
eased/healthy population. This formula is similar to that used for the glm() function, except that nonpara-
metric functions (modelled by means of B-spline basis functions) can be added by means of function f().
For instance, specification y ∼ x1 + f(x2, K = 0) assumes a linear effect of x1 and a nonparametric effect
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of x2. The argument K = 0 indicates that 0 internal knots will be used. Categorical variables (factors) can
be also incorporated, as well as factor-by-curve interaction terms. For example, to include the interaction
between age and gender we need to specify y ∼ gender + s(age, by = gender, K = 0). The name of
the variable that distinguishes nondiseased from diseased individuals is represented by argument group, and
the value codifying the nondiseased individuals in group is specified by tag.healthy. The data argument
is a data frame containing the data and all needed variables. The argument scale = TRUE is used to indi-
cate that test outcomes will be scaled, i.e., divided by the standard deviation (and then transformed to the
original scale when presenting the results). The set of FPFs at which to estimate the pooled ROC curve is
indicated in p. The log pseudo marginal likelihood (LPML) and the widely applicable information criterion
(WAIC) can be computed by setting the arguments compute.lpml and compute.WAIC to TRUE. The arguments
m0, S0, nu, Psi, a, b are the hyperparameters associated with the centering distribution. Note that in
this case the hyperparameter specification is made on the scaled data (scale = TRUE). Finally, in argument
L the user specifies the maximum number of mixture components for the B-splines DDP mixture model, and
nsim and nburn are, respectively, the total number of Gibbs sampler iterates (including the burn-in period)
and the number of burn-in iterations. As before, a numerical summary can be obtained by calling the function
summary
summary(psa_aroc_bnp)
##
## Call:
## AROC.bnp(formula.healthy = l_marker1 ~ f(age, K = 0), group = "status",
## tag.healthy = 0, data = newpsa, scale = TRUE, p = seq(0,
## 1, l = 101), compute.lpml = TRUE, compute.WAIC = TRUE,
## m0 = rep(0, 4), S0 = 100 * diag(4), nu = 6, Psi = diag(4),
## a = 2, b = 0.5, L = 10, nsim = 50000, nburn = 5000)
##
## Approach: AROC Bayesian nonparametric
## ----------------------------------------------
## Area under the covariate-adjusted ROC curve: 0.88 (0.812, 0.933)
##
##
## Model selection criteria - Healthy population
## ----------------------------------------------
## Widely applicable information criterion (WAIC): 193.165
## Pseudo marginal likelihood (LPML): -97
Note that the summary function provides the WAIC and LPML. Graphical results in this case can be obtained
using functions plot and predictive.checks.AROC.bnp. Specifically, the estimated AROC curve and AAUC,
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jointly with 95% credible intervals, is obtained using the function plot. The function
predictive.checks.AROC.bnp depicts the histograms of several test statistics computed from datasets drawn
from the posterior predictive distribution in the nondiseased group, jointly with the estimated test statistics
from the observed diagnostic test outcomes in the nondiseased group. The function also provides the ker-
nel density estimate of the observed diagnostic test outcomes in the nondiseased group and the kernel density
estimates for 500 simulated datasets drawn from the posterior predictive distribution in the nondiseased group.
plot(psa_aroc_bnp)
predictive.checks.AROC.bnp(psa_aroc_bnp, statistics = c("skewness","kurtosis"))
The results are shown in Web Figures 1(b) and 2(a). We finish this Web Appendix by showing the
code needed for estimating the age-adjusted ROC (AROC) curve using the Bayesian semiparametric model
discussed in Section 4 of the main document (function AROC.bsp), and the kernel-based method proposed by
Rodr´ıguez-A´lvarez et al. (2011) (function AROC.kernel). For the sake of simplicity, we do not describe here
either the usage of the functions or the input arguments they require. This information can be found in the
documentation files of the package.
# Bayesian semiparametric approach
set.seed(123) # for reproducibility
psa_aroc_bsp <- AROC.bsp(formula.healthy = l_marker1 ~ age,
group = "status", tag.healthy = 0, data = newpsa, scale = TRUE,
p = seq(0,1,l=101), compute.lpml = TRUE, compute.WAIC = TRUE,
m0 = rep(0,2), S0 = 100*diag(2), nu=4,
Psi=diag(2), a = 2, b = 0.5, nsim = 50000, nburn = 5000)
# Kernel based approach
set.seed(123) # for reproducibility
psa_aroc_kernel <- AROC.kernel(marker = "l_marker1", covariate = "age",
group = "status", tag.healthy = 0, data = newpsa,
p = seq(0,1,l=101), B = 500)
Numerical and graphical summaries are obtained as follows
summary(psa_aroc_bsp)
##
## Call:
## AROC.bsp(formula.healthy = l_marker1 ~ age, group = "status",
## tag.healthy = 0, data = newpsa, scale = TRUE, p = seq(0,
## 1, l = 101), compute.lpml = TRUE, compute.WAIC = TRUE,
## m0 = rep(0, 2), S0 = 100 * diag(2), nu = 4, Psi = diag(2),
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## a = 2, b = 0.5, nsim = 50000, nburn = 5000)
##
## Approach: AROC Bayesian semiparametric
## ----------------------------------------------
## Area under the covariate-adjusted ROC curve: 0.887 (0.826, 0.934)
##
##
## Model selection criteria - Healthy population
## ----------------------------------------------
## Widely applicable information criterion (WAIC): 198.447
## Pseudo marginal likelihood (LPML): -99
summary(psa_aroc_kernel)
##
## Call:
## AROC.kernel(marker = "l_marker1", covariate = "age", group = "status",
## tag.healthy = 0, data = newpsa, p = seq(0, 1, l = 101), B = 500)
##
## Approach: AROC Kernel-based
## ----------------------------------------------
## Area under the covariate-adjusted ROC curve: 0.891 (0.835, 0.942)
plot(psa_aroc_bsp)
predictive.checks.AROC.bsp(psa_aroc_bsp, statistics = c("skewness","kurtosis"))
plot(psa_aroc_kernel)
The graphical results are shown in Web Figures 1(c), 2(b) and 1(d). The code for plotting all results using
the R-package ggplot2 (Wickham, 2009) (similarly to how results are presented in the main paper) is
library(ggplot2)
p <- seq(0, 1, l = 101)
df <- data.frame(Approach = rep(c("AROC Bayesian Nonparam.", "AROC Bayesian Semipar",
"AROC Kernel-based", "Pooled"), each = length(p)), x = rep(p, 4),
y = c(psa_aroc_bnp$ROC[,1], psa_aroc_bsp$ROC[,1],
psa_aroc_kernel$ROC[,1], psa_pooled$ROC[,1]),
ql = c(psa_aroc_bnp$ROC[,2], psa_aroc_bsp$ROC[,2],
psa_aroc_kernel$ROC[,2], psa_pooled$ROC[,2]),
qh = c(psa_aroc_bnp$ROC[,3], psa_aroc_bsp$ROC[,3],
psa_aroc_kernel$ROC[,3], psa_pooled$ROC[,3]))
g0 <- ggplot(df, aes(x = x, y = y, ymin = ql, ymax = qh)) +
geom_line(aes(colour = Approach, linetype = Approach), size = 1) +
scale_color_manual(values = c("#F8766D", "#7CAE00", "#00BFC4", "#C77CFF")) +
geom_ribbon(aes(fill = Approach), alpha = 0.2) +
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scale_fill_manual(values = c("#F8766D", "#7CAE00", "#00BFC4", "#C77CFF")) +
scale_linetype_manual(values=c("dashed", "longdash","twodash", "dotdash")) +
guides(colour=guide_legend(keywidth = 3, keyheight = 1)) +
labs(title = "Age-adjusted and pooled ROC curves", x = "FPF", y = "TPF") +
theme(legend.position = c(0.7, 0.15),
plot.title = element_text(hjust = 0.5, size = 20),
axis.text = element_text(size=20),
axis.title = element_text(size=20),
legend.title = element_text(size=15),
legend.text = element_text(size=15))
print(g0)
The result is shown in Web Figure 3.
0.0 0.2 0.4 0.6 0.8 1.0
0.
0
0.
2
0.
4
0.
6
0.
8
1.
0
Pooled ROC curve − Bayesian bootstrap
FPF
TP
F
AUC: 0.878 (0.815, 0.928)
(a) pooledROC.BB
0.0 0.2 0.4 0.6 0.8 1.0
0.
0
0.
2
0.
4
0.
6
0.
8
1.
0
AROC Bayesian nonparametric
FPF
TP
F
AAUC: 0.88 (0.812, 0.933)
(b) AROC.bnp
0.0 0.2 0.4 0.6 0.8 1.0
0.
0
0.
2
0.
4
0.
6
0.
8
1.
0
AROC Bayesian semiparametric
FPF
TP
F
AAUC: 0.887 (0.826, 0.934)
(c) AROC.bsp
0.0 0.2 0.4 0.6 0.8 1.0
0.
0
0.
2
0.
4
0.
6
0.
8
1.
0
AROC Kernel−based
FPF
TP
F
AAUC: 0.891 (0.835, 0.942)
(d) AROC.kernel
Web Figure 1: PSA CARET data: graphical results as provided by the AROC package.
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Web Figure 2: PSA CARET data: posterior predictive checks as provided by the AROC package
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Web Figure 3: PSA CARET data: estimated age-adjusted ROC (AROC) curve and 95% intervals by means
of our Bayesian nonparametric proposal (Bayesian Nonparam.), the Bayesian semiparametric model (Bayesian
Semipar.), and the kernel-based approach (Rodr´ıguez-A´lvarez et al., 2011). For comparison purposes, the
estimated pooled ROC curve is also depicted.
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Web Appendix E SUPPORTING FIGURES AND TABLES FOR THE SIMULATION STUDY
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Web Figure 4: (a) Simulated covariate distribution in the nondiseased group (blue line) and in the diseased
group (red line). Endocrine data: kernel density estimate of age in men (panel (b)) and in women (panel (c)).
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Web Appendix E.1 Results for four interior knots (K = 4)
Web Table 1: Bias (standard deviation) (× 100), across simulations, of the AUC for the different approaches
under consideration and for K = 4. The results are presented for each of the simulated scenarios and sample
sizes.
Sample size
(nD¯, nD)
Scenario Approach (50, 50) (200, 70) (200, 200) (300, 100)
I
Bayesian nonparametric -0.620 (6.140) -0.228 (4.293) 0.383 (3.104) 0.474 (3.944)
Bayesian semiparametric 0.422 (6.264) -0.133 (4.224) 0.556 (2.955) 0.525 (3.974)
Kernel 0.680 (6.346) 0.010 (4.261) 0.676 (2.947) 0.650 (3.963)
Pooled 0.632 (6.040) -0.053 (4.249) 0.609 (2.895) 0.599 (3.897)
II
Bayesian nonparametric -0.625 (6.114) -0.235 (4.294) 0.380 (3.090) 0.472 (3.946)
Bayesian semiparametric 0.404 (6.245) -0.127 (4.206) 0.550 (2.958) 0.524 (3.970)
Kernel 1.697 (6.378) 0.655 (4.314) 1.343 (3.043) 1.173 (3.981)
Pooled 4.134 (5.354) 3.270 (4.131) 3.828 (2.767) 3.924 (3.577)
III
Bayesian nonparametric -0.749 (6.110) -0.212 (4.347) 0.311 (3.092) 0.456 (3.926)
Bayesian semiparametric 0.448 (6.139) -0.089 (4.247) 0.503 (2.955) 0.501 (3.947)
Kernel 1.578 (6.230) 0.569 (4.342) 1.139 (2.992) 1.056 (3.961)
Pooled 2.557 (5.595) 1.715 (4.251) 2.206 (2.848) 2.293 (3.764)
IV
Bayesian nonparametric -0.648 (5.769) -0.071 (3.902) 0.670 (2.797) 0.126 (4.004)
Bayesian semiparametric 1.869 (5.618) 1.922 (3.487) 2.383 (2.782) 2.359 (3.804)
Kernel 1.483 (5.771) 0.957 (4.099) 1.521 (3.023) 0.948 (4.142)
Pooled 9.262 (3.785) 8.728 (2.522) 9.130 (2.014) 9.281 (2.270)
V
Bayesian nonparametric -1.616 (4.845) -0.740 (3.956) -0.558 (2.370) -0.723 (3.385)
Bayesian semiparametric -1.942 (5.853) -1.731 (3.479) -1.609 (3.133) -1.573 (2.767)
Kernel - - - -
Pooled 5.921 (4.077) 5.451 (3.150) 5.786 (1.840) 5.396 (2.318)
VI
Bayesian nonparametric -2.881 (5.090) -0.759 (4.086) -0.314 (3.175) -0.105 (3.733)
Bayesian semiparametric -3.867 (5.757) -4.067 (3.805) -3.357 (3.183) -3.183 (3.744)
Kernel - - - -
Pooled -7.565 (4.812) -6.870 (3.850) -6.173 (3.092) -5.813 (3.662)
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Web Table 2: 95% coverage probabilities for the AAUC for the different approaches under consideration and
for K = 4. The results are presented for each of the simulated scenarios and sample sizes.
Sample size
(nD¯, nD)
Scenario Approach (50, 50) (200, 70) (200, 200) (300, 100)
I
Bayesian nonparametric 94.0 96.0 94.0 94.0
Bayesian semiparametric 91.0 96.0 94.0 94.0
II
Bayesian nonparametric 94.0 97.0 93.0 94.0
Bayesian semiparametric 91.0 96.0 94.0 94.0
III
Bayesian nonparametric 94.0 95.0 93.0 94.0
Bayesian semiparametric 92.0 95.0 94.0 95.0
IV
Bayesian nonparametric 92.0 96.0 93.0 93.0
Bayesian semiparametric 89.0 91.0 81.0 80.0
V
Bayesian nonparametric 98.0 96.0 97.0 97.0
Bayesian semiparametric 95.0 93.0 90.0 92.0
VI
Bayesian nonparametric 98.0 96.0 94.0 96.0
Bayesian semiparametric 87.0 82.0 71.0 84.0
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Web Table 3: Percentage of time the WAIC/LPML is smaller/higher for the B-splines dependent Dirichlet
process (DDP) mixture of normals model with four interior knots (K = 4) against no interior knots (K = 0).
The results are presented for each of the simulated scenarios and sample sizes (in the nondiseased group).
Sample size
nD¯
Scenario Approach 50 200 300
I
WAIC (K = 4) < WAIC (K = 0) 15% 5% 6%
LPML (K = 4) > LPML (K = 0) 13% 5% 4%
II
WAIC (K = 4) < WAIC (K = 0) 11% 5% 5%
LPML (K = 4) > LPML (K = 0) 9% 6% 4%
III
WAIC (K = 4) < WAIC (K = 0) 13% 4% 6%
LPML (K = 4) > LPML (K = 0) 10% 4% 3%
IV
WAIC (K = 4) < WAIC (K = 0) 45% 98% 100%
LPML (K = 4) > LPML (K = 0) 39% 97% 100%
V
WAIC (K = 4) < WAIC (K = 0) 3% 1% 1%
LPML (K = 4) > LPML (K = 0) 1% 1% 1%
VI
WAIC (K = 4) < WAIC (K = 0) 15% 58% 80%
LPML (K = 4) > LPML (K = 0) 9% 50% 76%
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Web Table 4: For K = 4: percentage of time the WAIC/LPML is smaller/higher for the Bayesian normal
linear (BNL) model against our B-splines dependent Dirichlet process (DDP) mixture of normals model with
K = 4. The results are presented for each of the simulated scenarios and sample sizes (in the nondiseased
group).
Sample size
nD¯
Scenario Approach 50 200 300
I
WAIC (BNL) < WAIC (DDP) 86% 97% 99%
LPML (BNL) > LPML (DDP) 91% 97% 100%
II
WAIC (BNL) < WAIC (DDP) 88% 97% 100%
LPML (BNL) > LPML (DDP) 92% 97% 100%
III
WAIC (BNL) < WAIC (DDP) 88% 97% 100%
LPML (BNL) > LPML (DDP) 91% 97% 100%
IV
WAIC (BNL) < WAIC (DDP) 3% 0% 0%
LPML (BNL) > LPML (DDP) 4% 0% 0%
V
WAIC (BNL) < WAIC (DDP) 0% 0% 0%
LPML (BNL) > LPML (DDP) 0% 0% 0%
VI
WAIC (BNL) < WAIC (DDP) 3% 0% 0%
LPML (BNL) > LPML (DDP) 11% 0% 0%
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Web Figure 5: Scenario I and K = 4: true (solid black line) and average value of 100 simulated datasets
(dashed lines) of the posterior mean (for the Bayesian estimators) of the covariate adjusted ROC curve/pooled
ROC curve for the different approaches under consideration and sample sizes.
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Web Figure 6: Scenario II and K = 4 : true (solid black line) and average value of 100 simulated datasets
(dashed lines) of the posterior mean (for the Bayesian estimators) of the covariate adjusted ROC curve/pooled
ROC curve for the different approaches under consideration and sample sizes.
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Web Figure 7: Scenario III and K = 4: true (solid black line) and average value of 100 simulated datasets
(dashed lines) of the posterior mean (for the Bayesian estimators) of the covariate adjusted ROC curve/pooled
ROC curve for the different approaches under consideration and sample sizes.
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Web Figure 8: Scenario IV and K = 4: true (solid black line) and average value of 100 simulated datasets
(dashed lines) of the posterior mean (for the Bayesian estimators) of the covariate adjusted ROC curve/pooled
ROC curve for the different approaches under consideration and sample sizes.
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Web Figure 9: Scenario V and K = 4: true (solid black line) and average value of 100 simulated datasets
(dashed lines) of the posterior mean (for the Bayesian estimators) of the covariate adjusted ROC curve/pooled
ROC curve for the different approaches under consideration and sample sizes.
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Web Figure 10: Scenario VI and K = 4: true (solid black line) and average value of 100 simulated datasets
(dashed lines) of the posterior mean (for the Bayesian estimators) of the covariate adjusted ROC curve/pooled
ROC curve for the different approaches under consideration and sample sizes.
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Web Figure 11: Scenario I and K = 4: true (solid black line) and average value of 100 simulated datasets
(dashed lines) of the posterior mean (for the Bayesian estimators) of the thresholds used for defining a positive
test result. The shaded area are bands constructed using the pointwise 2.5% and 97.5% quantiles across
simulations.
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Web Figure 12: Scenario II and K = 4: true (solid black line) and average value of 100 simulated datasets
(dashed lines) of the posterior mean (for the Bayesian estimators) of the thresholds used for defining a positive
test result. The shaded area are bands constructed using the pointwise 2.5% and 97.5% quantiles across
simulations.
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Web Figure 13: Scenario III and K = 4: true (solid black line) and average value of 100 simulated datasets
(dashed lines) of the posterior mean (for the Bayesian estimators) of the thresholds used for defining a positive
test result. The shaded area are bands constructed using the pointwise 2.5% and 97.5% quantiles across
simulations.
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Web Figure 14: Scenario IV and K = 4: true (solid black line) and average value of 100 simulated datasets
(dashed lines) of the posterior mean (for the Bayesian estimators) of the thresholds used for defining a positive
test result. The shaded area are bands constructed using the pointwise 2.5% and 97.5% quantiles across
simulations.
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Web Appendix E.2 Comparison results between no interior knots (K = 0) and four in-
terior knots (K = 4)
Web Table 5: Average (standard deviation) (× 100), across simulations, of the empirical root mean squared
error for the Bayesian nonparametric approach proposed in this paper for four interior knots (K = 4) and no
interior knots (K = 0). The results are presented for each of the simulated scenarios and sample sizes.
Sample size
(nD¯, nD)
Scenario Approach (50, 50) (200, 70) (200, 200) (300, 100)
I
Bayesian nonparametric (K = 0) 6.266 (3.443) 4.443 (2.275) 3.250 (1.585) 4.197 (2.150)
Bayesian nonparametric (K = 4) 6.013 (3.494) 4.438 (2.296) 3.174 (1.644) 4.070 (2.121)
II
Bayesian nonparametric (K = 0) 6.212 (3.422) 4.434 (2.278) 3.237 (1.581) 4.194 (2.154)
Bayesian nonparametric (K = 4) 5.990 (3.498) 4.434 (2.293) 3.164 (1.630) 4.071 (2.124)
III
Bayesian nonparametric (K = 0) 6.124 (3.383) 4.416 (2.297) 3.292 (1.524) 4.205 (2.178)
Bayesian nonparametric (K = 4) 6.021 (3.454) 4.405 (2.324) 3.196 (1.592) 4.118 (2.133)
IV
Bayesian nonparametric (K = 0) 6.218 (2.986) 4.355 (2.260) 3.212 (1.489) 4.195 (1.943)
Bayesian nonparametric (K = 4) 6.060 (3.249) 3.973 (2.288) 2.914 (1.539) 3.888 (2.085)
V
Bayesian nonparametric (K = 0) 5.521 (2.282) 4.109 (2.206) 2.588 (1.429) 3.785 (1.679)
Bayesian nonparametric (K = 4) 6.361 (2.832) 5.553 (1.944) 4.394 (1.316) 4.646 (1.396)
VI
Bayesian nonparametric (K = 0) 5.463 (3.024) 4.497 (2.182) 3.158 (1.669) 4.021 (2.135)
Bayesian nonparametric (K = 4) 5.673 (3.056) 4.304 (2.180) 3.063 (1.748) 3.781 (2.120)
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Web Table 6: Bias (standard deviation) (× 100), across simulations, of the AAUC for the Bayesian nonpara-
metric approach proposed in this paper for four interior knots (K = 4) and no interior knots (K = 0). The
results are presented for each of the simulated scenarios and sample sizes.
Sample size
(nD¯, nD)
Scenario Approach (50, 50) (200, 70) (200, 200) (300, 100)
I
Bayesian nonparametric (K = 0) -0.045 (6.169) -0.149 (4.235) 0.507 (3.049) 0.540 (4.015)
Bayesian nonparametric (K = 4) -0.620 (6.140) -0.228 (4.293) 0.383 (3.104) 0.474 (3.944)
II
Bayesian nonparametric (K = 0) -0.081 (6.101) -0.161 (4.236) 0.501 (3.050) 0.530 (4.018)
Bayesian nonparametric (K = 4) -0.625 (6.114) -0.235 (4.294) 0.380 (3.090) 0.472 (3.946)
III
Bayesian nonparametric (K = 0) -0.128 (6.035) -0.146 (4.288) 0.435 (3.045) 0.514 (3.994)
Bayesian nonparametric (K = 4) -0.749 (6.110) -0.212 (4.347) 0.311 (3.092) 0.456 (3.926)
IV
Bayesian nonparametric (K = 0) -0.422 (5.767) 0.080 (3.886) 0.756 (2.848) 0.312 (3.985)
Bayesian nonparametric (K = 4) -0.648 (5.769) -0.071 (3.902) 0.670 (2.797) 0.126 (4.004)
V
Bayesian nonparametric (K = 0) 0.097 (4.949) 0.062 (3.889) 0.200 (2.409) -0.177 (3.535)
Bayesian nonparametric (K = 4) -1.616 (4.845) -0.740 (3.956) -0.558 (2.370) -0.723 (3.385)
VI
Bayesian nonparametric (K = 0) -1.878 (5.178) -0.686 (4.151) -0.209 (3.115) -0.106 (3.851)
Bayesian nonparametric (K = 4) -2.881 (5.090) -0.759 (4.086) -0.314 (3.175) -0.105 (3.733)
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Web Table 7: 95% coverage probabilities for the AROC (average over all FPFs) for the Bayesian nonparametric
approach proposed in this paper for four interior knots (K = 4) and no interior knots (K = 0). The results
are presented for each of the simulated scenarios and sample sizes.
Sample size
(nD¯, nD)
Scenario Approach (50, 50) (200, 70) (200, 200) (300, 100)
I
Bayesian nonparametric (K = 0) 95.0 95.0 94.0 94.0
Bayesian nonparametric (K = 4) 96.0 95.0 95.0 95.0
II
Bayesian nonparametric (K = 0) 95.0 95.0 95.0 95.0
Bayesian nonparametric (K = 4) 96.0 96.0 94.0 95.0
III
Bayesian nonparametric (K = 0) 95.0 95.0 95.0 94.0
Bayesian nonparametric (K = 4) 96.0 95.0 95.0 94.0
IV
Bayesian nonparametric (K = 0) 95.0 94.0 92.0 93.0
Bayesian nonparametric (K = 4) 96.0 96.0 93.0 93.0
V
Bayesian nonparametric (K = 0) 96.0 95.0 95.0 96.0
Bayesian nonparametric (K = 4) 97.0 95.0 95.0 96.0
VI
Bayesian nonparametric (K = 0) 97.0 96.0 94.0 94.0
Bayesian nonparametric (K = 4) 98.0 97.0 96.0 95.0
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Web Table 8: 95% coverage probabilities for the AAUC for the Bayesian nonparametric approach proposed in
this paper for four interior knots (K = 4) and no interior knots (K = 0). The results are presented for each
of the simulated scenarios and sample sizes.
Sample size
(nD¯, nD)
Scenario Approach (50, 50) (200, 70) (200, 200) (300, 100)
I
Bayesian nonparametric (K = 0) 93.0 96.0 94.0 94.0
Bayesian nonparametric (K = 4) 94.0 96.0 94.0 94.0
II
Bayesian nonparametric (K = 0) 93.0 96.0 93.0 94.0
Bayesian nonparametric (K = 4) 94.0 97.0 93.0 94.0
III
Bayesian nonparametric (K = 0) 94.0 92.0 94.0 95.0
Bayesian nonparametric (K = 4) 94.0 95.0 93.0 94.0
IV
Bayesian nonparametric (K = 0) 95.0 97.0 91.0 92.0
Bayesian nonparametric (K = 4) 92.0 96.0 93.0 93.0
V
Bayesian nonparametric (K = 0) 97.0 97.0 95.0 96.0
Bayesian nonparametric (K = 4) 98.0 96.0 97.0 97.0
VI
Bayesian nonparametric (K = 0) 95.0 95.0 91.0 95.0
Bayesian nonparametric (K = 4) 98.0 96.0 94.0 96.0
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Web Table 9: For K = 0: percentage of time the WAIC/LPML is smaller/higher for the Bayesian normal
linear (BNL) model against our B-splines dependent Dirichlet process (DDP) mixture of normals model with
K = 0. The results are presented for each of the simulated scenarios and sample sizes (in the nondiseased
group).
Sample size
nD¯
Scenario Approach 50 200 300
1
WAIC (BNL) < WAIC (DDP) 78% 89% 92%
LPML (BNL) > LPML (DDP) 82% 89% 92%
2
WAIC (BNL) < WAIC (DDP) 80% 90% 94%
LPML (BNL) > LPML (DDP) 83% 93% 94%
3
WAIC (BNL) < WAIC (DDP) 79% 90% 92%
LPML (BNL) > LPML (DDP) 83% 92% 92%
4
WAIC (BNL) < WAIC (DDP) 1% 0% 0%
LPML (BNL) > LPML (DDP) 1% 0% 0%
5
WAIC (BNL) < WAIC (DDP) 0% 0% 0%
LPML (BNL) > LPML (DDP) 0% 0% 0%
6
WAIC (BNL) < WAIC (DDP) 0% 0% 0%
LPML (BNL) > LPML (DDP) 0% 0% 0%
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Web Figure 15: Scenario I: true (solid black line) and average value of 100 simulated datasets (dashed lines)
of the posterior mean of the covariate adjusted ROC curve/pooled ROC curve for the Bayesian nonparametric
approach proposed in this paper. The shaded area are bands constructed using the pointwise 2.5% and 97.5%
quantiles across simulations. The results are presented for no interior knots (K = 0) and four interior knots
(K = 4) and for each sample size.
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Web Figure 16: Scenario II: true (solid black line) and average value of 100 simulated datasets (dashed lines)
of the posterior mean of the covariate adjusted ROC curve/pooled ROC curve for the Bayesian nonparametric
approach proposed in this paper. The shaded area are bands constructed using the pointwise 2.5% and 97.5%
quantiles across simulations. The results are presented for no interior knots (K = 0) and four interior knots
(K = 4) and for each sample size.
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Web Figure 17: Scenario III: true (solid black line) and average value of 100 simulated datasets (dashed lines)
of the posterior mean of the covariate adjusted ROC curve/pooled ROC curve for the Bayesian nonparametric
approach proposed in this paper. The shaded area are bands constructed using the pointwise 2.5% and 97.5%
quantiles across simulations. The results are presented for no interior knots (K = 0) and four interior knots
(K = 4) and for each sample size.
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Web Figure 18: Scenario IV: true (solid black line) and average value of 100 simulated datasets (dashed lines)
of the posterior mean of the covariate adjusted ROC curve/pooled ROC curve for the Bayesian nonparametric
approach proposed in this paper. The shaded area are bands constructed using the pointwise 2.5% and 97.5%
quantiles across simulations. The results are presented for no interior knots (K = 0) and four interior knots
(K = 4) and for each sample size.
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Web Figure 19: Scenario V: true (solid black line) and average value of 100 simulated datasets (dashed lines)
of the posterior mean of the covariate adjusted ROC curve/pooled ROC curve for the Bayesian nonparametric
approach proposed in this paper. The shaded area are bands constructed using the pointwise 2.5% and 97.5%
quantiles across simulations. The results are presented for no interior knots (K = 0) and four interior knots
(K = 4) and for each sample size.
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Web Figure 20: Scenario VI: true (solid black line) and average value of 100 simulated datasets (dashed lines)
of the posterior mean of the covariate adjusted ROC curve/pooled ROC curve for the Bayesian nonparametric
approach proposed in this paper. The shaded area are bands constructed using the pointwise 2.5% and 97.5%
quantiles across simulations. The results are presented for no interior knots (K = 0) and four interior knots
(K = 4) and for each sample size.
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Web Figure 21: Scenario I: true (solid black line) and average value of 100 simulated datasets (dashed lines)
of the posterior mean of the thresholds used for defining a positive test result for the Bayesian nonparametric
approach proposed in this paper. The shaded area are bands constructed using the pointwise 2.5% and 97.5%
quantiles across simulations. The results are presented for no interior knots (K = 0) and four interior knots
(K = 4) and for each sample size.
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Web Figure 22: Scenario II: true (solid black line) and average value of 100 simulated datasets (dashed lines)
of the posterior mean of the thresholds used for defining a positive test result for the Bayesian nonparametric
approach proposed in this paper. The shaded area are bands constructed using the pointwise 2.5% and 97.5%
quantiles across simulations. The results are presented for no interior knots (K = 0) and four interior knots
(K = 4) and for each sample size.
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Web Figure 23: Scenario III: true (solid black line) and average value of 100 simulated datasets (dashed lines)
of the posterior mean of the thresholds used for defining a positive test result for the Bayesian nonparametric
approach proposed in this paper. The shaded area are bands constructed using the pointwise 2.5% and 97.5%
quantiles across simulations. The results are presented for no interior knots (K = 0) and four interior knots
(K = 4) and for each sample size.
74
−10
−5
0
5
10
15
0 5 10
Covariate values
Te
st
 o
ut
cc
om
e
Approach
AROC Bayesian Nonparam. (K = 0)
AROC Bayesian Nonparam. (K = 4)
Threshold values − Scenario IV − FPF = 0.1
(nD, nD) = (50, 50)
−5.0
−2.5
0.0
0 5 10
Covariate values
Te
st
 o
ut
cc
om
e
Approach
AROC Bayesian Nonparam. (K = 0)
AROC Bayesian Nonparam. (K = 4)
Threshold values − Scenario IV − FPF = 0.1
(nD, nD) = (200, 70)
−5.0
−2.5
0.0
0 5 10
Covariate values
Te
st
 o
ut
cc
om
e
Approach
AROC Bayesian Nonparam. (K = 0)
AROC Bayesian Nonparam. (K = 4)
Threshold values − Scenario IV − FPF = 0.1
(nD, nD) = (200, 200)
−5.0
−2.5
0.0
0 5 10
Covariate values
Te
st
 o
ut
cc
om
e
Approach
AROC Bayesian Nonparam. (K = 0)
AROC Bayesian Nonparam. (K = 4)
Threshold values − Scenario IV − FPF = 0.1
(nD, nD) = (300, 100)
(a) FPF = 0.1
−10
−5
0
5
10
0 5 10
Covariate values
Te
st
 o
ut
cc
om
e
Approach
AROC Bayesian Nonparam. (K = 0)
AROC Bayesian Nonparam. (K = 4)
Threshold values − Scenario IV − FPF = 0.3
(nD, nD) = (50, 50)
−5.0
−2.5
0.0
0 5 10
Covariate values
Te
st
 o
ut
cc
om
e
Approach
AROC Bayesian Nonparam. (K = 0)
AROC Bayesian Nonparam. (K = 4)
Threshold values − Scenario IV − FPF = 0.3
(nD, nD) = (200, 70)
−5.0
−2.5
0.0
0 5 10
Covariate values
Te
st
 o
ut
cc
om
e
Approach
AROC Bayesian Nonparam. (K = 0)
AROC Bayesian Nonparam. (K = 4)
Threshold values − Scenario IV − FPF = 0.3
(nD, nD) = (200, 200)
−5.0
−2.5
0.0
0 5 10
Covariate values
Te
st
 o
ut
cc
om
e
Approach
AROC Bayesian Nonparam. (K = 0)
AROC Bayesian Nonparam. (K = 4)
Threshold values − Scenario IV − FPF = 0.3
(nD, nD) = (300, 100)
(b) FPF = 0.3
Web Figure 24: Scenario IV: true (solid black line) and average value of 100 simulated datasets (dashed lines)
of the posterior mean of the thresholds used for defining a positive test result for the Bayesian nonparametric
approach proposed in this paper. The shaded area are bands constructed using the pointwise 2.5% and 97.5%
quantiles across simulations. The results are presented for no interior knots (K = 0) and four interior knots
(K = 4) and for each sample size.
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Web Appendix F SUPPORTING FIGURES AND TABLES FOR THE APPLICATION
Diseased Nondiseased
Global sample 29.39 (27.00, 32.60) 25.14 (22.44, 28.34)
Gender
Female 30.49 (27.43, 34.57) 24.39 (21.78, 27.72)
Male 29.10 (26.83, 31.79) 25.89 (23.58, 28.81)
Age
≤ 29.6 27.75 (24.80, 32.09) 22.96 (21.00, 25.87)
(29.6, 39.3] 29.38 (26.71, 32.84) 24.78 (22.48, 27.68)
(39.3, 50.8] 29.19 (26.68, 32.69) 25.99 (23.73, 29.00)
> 50.8 29.94 (27.61, 32.58) 28.09 (25.59, 30.92)
Web Table 10: Median (interquartile range) of the body mass index (BMI) in diseased and nondiseased
individuals, males and females, and for four gender strata based on quartiles.
K
Global Gender
sample Female Male
WAIC LPML WAIC LPML WAIC LPML
0 11736 -5868 6904 -3452 4836 -2418
1 11739 -5870 6906 -3454 4837 -2419
2 11744 -5873 6908 -3454 4838 -2419
3 11754 -5877 6912 -3456 4842 -2421
4 11762 -5881 6916 -3458 4845 -2423
Web Table 11: WAIC and LPML for the Bayesian nonparametric approach for different number of inner knots
and for the analysis using the global sample, and in females and males separately.
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α L m0 S0 ν Ψ
−1 a b
Prior 1 0.1 30 08 100I8 10 I8 2 0.5
Prior 2 10 30 08 100I8 10 I8 2 0.5
Prior 3 1 10 08 100I8 10 I8 2 3
Web Table 12: Hyperparameter specification used in the sensitivity analysis.
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